Table of Contents

----

----

| x |     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---|-----------------------------------------------------------------------------------------------------------------|

|  ̈ |     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|--------|-------------------------------------------------------------------------------------------------------------------|

| Delaware(State or Other Jurisdiction of Incorporation or Organization)                           | 90-0649687(I.R.S. Employer Identification No.) |
|--------------------------------------------------------------------------------------------------|------------------------------------------------|
| 811 Hansen Way, Palo Alto, California 94303(Address of Principal Executive Offices and Zip Code) |
| (650) 846-2900(Registrant’s telephone number, including area code)                         |
| Not Applicable(Former name, former address and former fiscal year, if changed since last report) |

| Large accelerated filer  |  ̈                                    | Accelerated filer         |  ̈  |
|--------------------------------|-------------------------------------------------|---------------------------|---------------|
| Non-accelerated filer    | x (Do not check if a smaller reporting company) | Smaller reporting company |  ̈        |

----

----

----

10-Q REPORT

|   |   |    Page |
|--------|--------|-------------------|

|     |
|----------|
| Part I:  | FINANCIAL INFORMATION |   4 |
|     |   |   |   |
|     | Item 1. | Unaudited Condensed Consolidated Financial Statements |   4 |
|     |   | Condensed Consolidated Balance Sheets as of July 1, 2011 and October 1, 2010 |   4 |
|     |   | Condensed Consolidated Statements of Operations and Comprehensive Income for the Three Months Ended July 1, 2011 and July 2, 2010 |   5 |
|     |   | Consolidated Statements of Operations and Comprehensive Income for the Periods February 11, 2011 to July 1, 2011, October 2, 2010 to February 10, 2011 and Nine Months Ended July 2, 2010 |    6 |
|     |   | Condensed Consolidated Statements of Cash Flows for the Periods February 11, 2011 to July 1, 2011, October 2, 2010 to February 10, 2011 and Nine Months Ended July 2, 2010  |     7 |
|     |   | Notes to Unaudited Condensed Consolidated Financial Statements  |   8 |
|     | Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 46 |
|     | Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 63 |
|     | Item 4. | Controls and Procedures | 64 |
|     |   |   |   |
| Part II: | OTHER INFORMATION | 65 |
|     |   |   |   |
|     | Item 1. | Legal Proceedings | 65 |
|     | Item 1A. | Risk Factors | 65 |
|     | Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 65 |
|     | Item 3. | Defaults Upon Senior Securities | 65 |
|     | Item 4. | (Removed and Reserved) | 65 |
|     | Item 5. | Other Information | 65 |
|     | Item 6. | Exhibits | 66 |

----

----

Table of Contents

FINANCIAL INFORMATION

Item 1.              Unaudited Condensed Consolidated Financial Statements

CONDENSED CONSOLIDATED BALANCE SHEETS

|                                                                                                                                                                                                       |   | July 1,     |    |   | October 1,    |   |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------|---------|--------|---------------|--------|
|                                                                                                                                                                                                       |   | 2011        |    |   | 2010          |   |
|                                                                                                                                                                                                       |   | (Successor) |    |   | (Predecessor) |   |
| Assets                                                                                                                                                                                                     |   |        |    |   |          |   |
| Current Assets:                                                                                                                                                                                            |   |        |    |   |          |   |
| Cash and cash equivalents                                                                                                                                                                                  |   | $           | 31,924  |   |          | $      | 42,829 |   |
| Restricted cash                                                                                                                                                                                            |   |        | 1,538   |   |          |   | 1,804 |   |
| Accounts receivable, net                                                                                                                                                                                   |   |        | 44,828  |   |          |   | 45,707 |   |
| Inventories                                                                                                                                                                                                |   |        | 82,937  |   |          |   | 75,208 |   |
| Deferred tax assets                                                                                                                                                                                        |   |        | 10,433  |   |          |   | 11,030 |   |
| Prepaid and other current assets                                                                                                                                                                           |   |        | 6,330   |   |          |   | 6,459 |   |
| Total current assets                                                                                                                                                                                       |   |        | 177,990 |   |          |   | 183,037 |   |
| Property, plant, and equipment, net                                                                                                                                                                        |   |        | 81,653  |   |          |   | 54,259 |   |
| Deferred debt issue costs, net                                                                                                                                                                             |   |        | 14,196  |   |          |   | 1,604 |   |
| Intangible assets, net                                                                                                                                                                                     |   |        | 267,330 |   |          |   | 72,474 |   |
| Goodwill                                                                                                                                                                                                   |   |        | 181,141 |   |          |   | 162,225 |   |
| Other long-term assets                                                                                                                                                                                     |   |        | 5,160   |   |          |   | 4,677 |   |
| Total assets                                                                                                                                                                                               |   | $           | 727,470 |   |          | $      | 478,276 |   |
|                                                                                                                                                                                                       |   |        |    |   |          |   |   |   |
| Liabilities and stockholders’ equity                                                                                                                                                                 |   |        |    |   |          |   |   |   |
| Current Liabilities:                                                                                                                                                                                       |   |        |    |   |          |   |   |   |
| Current portion of long-term debt                                                                                                                                                                          |   | $           | 1,500   |   |          | $      | 66,000 |   |
| Accounts payable                                                                                                                                                                                           |   |        | 25,642  |   |          |   | 24,290 |   |
| Accrued expenses                                                                                                                                                                                           |   |        | 29,250  |   |          |   | 23,653 |   |
| Product warranty                                                                                                                                                                                           |   |        | 5,464   |   |          |   | 5,101 |   |
| Income taxes payable                                                                                                                                                                                       |   |        | 3,675   |   |          |   | 5,022 |   |
| Deferred income taxes                                                                                                                                                                                      |   |        | 14      |   |          |   | - |   |
| Advance payments from customers                                                                                                                                                                            |   |        | 15,669  |   |          |   | 12,670 |   |
| Billings in excess of costs and estimated earnings on uncompleted contracts                                                                                                                                |   |        | 2,788   |   |          |   | 1,548 |   |
| Total current liabilities                                                                                                                                                                                  |   |        | 84,002  |   |          |   | 138,284 |   |
| Deferred income taxes                                                                                                                                                                                      |   |        | 86,871  |   |          |   | 21,707 |   |
| Long-term debt, less current portion                                                                                                                                                                       |   |        | 362,043 |   |          |   | 128,934 |   |
| Other long-term liabilities                                                                                                                                                                                |   |        | 6,014   |   |          |   | 5,411 |   |
| Total liabilities                                                                                                                                                                                          |   |        | 538,930 |   |          |   | 294,336 |   |
| Commitments and contingencies                                                                                                                                                                              |   |        |    |   |          |   |   |   |
| Stockholders’ equity                                                                                                                                                                                 |   |        |    |   |          |   |   |   |
| Common stock (Successor: $0.01 par value, 2 shares authorized; 1 share issued and outstanding. Predecessor: $0.01 par value, 90,000 shares authorized; 17,020 shares issued and 16,813 shares outstanding) |   |        | -       |   |          |   | 170 |   |
| Additional paid-in capital                                                                                                                                                                                 |   |        | 197,320 |   |          |   | 80,015 |   |
| Accumulated other comprehensive income (loss)                                                                                                                                                              |   |        | 225     |   |          |   | (141 | ) |
| (Accumulated deficit) retained earnings                                                                                                                                                                    |   |        | (9,005  | )      |          |   | 106,696 |   |
| Treasury stock                                                                                                                                                                                             |   |        | -       |   |          |   | (2,800 | ) |
| Total stockholders’ equity                                                                                                                                                                           |   |        | 188,540 |   |          |   | 183,940 |   |
| Total liabilities and stockholders' equity                                                                                                                                                                 |   | $           | 727,470 |   |          | $      | 478,276 |   |

----

Table of Contents

CONDENSED CONSOLIDATED

|                                                                                                                                                                    |   | Three Months Ended |    |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------------------|---------|
|                                                                                                                                                                    |   | July 1,2011        |    |   | July 2,2010 |   |
|                                                                                                                                                                    |   | (Successor)        |    |   | (Predecessor) |   |
|  Sales                                                                                                                                                             |   | $                  | 104,206 |   |   | $ | 93,876 |   |
|  Cost of sales, including $3,907 of utilization of net increase in cost basis of inventory due to purchase accounting for the three months ended July 1, 2011 |   |               | 77,077  |   |   |   | 64,953 |   |
|  Gross profit                                                                                                                                                      |   |               | 27,129  |   |   |   | 28,923 |   |
|  Operating costs and expenses:                                                                                                                                     |   |               |    |   |   |   |   |   |
|  Research and development                                                                                                                                          |   |               | 3,269   |   |   |   | 3,542 |   |
|  Selling and marketing                                                                                                                                             |   |               | 5,300   |   |   |   | 5,178 |   |
|  General and administrative                                                                                                                                        |   |               | 6,427   |   |   |   | 6,373 |   |
|  Amortization of acquisition-related intangible assets                                                                                                             |   |               | 4,853   |   |   |   | 688 |   |
|  Strategic alternative transaction expenses                                                                                                                        |   |               | 344     |   |   |   | 3,589 |   |
|  Total operating costs and expenses                                                                                                                                |   |               | 20,193  |   |   |   | 19,370 |   |
|  Operating income                                                                                                                                                  |   |               | 6,936   |   |   |   | 9,553 |   |
|  Interest expense, net                                                                                                                                             |   |               | 6,811   |   |   |   | 3,780 |   |
|  Income before income taxes                                                                                                                                        |   |               | 125     |   |   |   | 5,773 |   |
|  Income tax expense                                                                                                                                                |   |               | 1,957   |   |   |   | 1,562 |   |
|  Net (loss) income                                                                                                                                                 |   | $                  | (1,832  | ) |   | $ | 4,211 |   |
|                                                                                                                                                                    |   |               |    |   |   |   |   |   |
|  Other comprehensive (loss) income, net of tax                                                                                                                     |   |               |    |   |   |   |   |   |
| Net unrealized loss on cash flow hedges and minimum pension liability adjustment                                                                                        |   |               | -       |   |   |   | (1,096 | ) |
|  Comprehensive (loss) income                                                                                                                                       |   | $                  | (1,832  | ) |   | $ | 3,115 |   |

----

Table of Contents

CONDENSED CONSOLIDATED

|                                                                                                                                                                    |   | Fiscal Year                     |    |
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|---------------------------------|---------|
|                                                                                                                                                                    |   | 2011                            |    |   | 2010 |   |
|                                                                                                                                                                    |   | February 11, 2011toJuly 1, 2011 |    |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine MonthsEndedJuly 2, 2010 |   |
|                                                                                                                                                                    |   | (Successor)                     |    |   | (Predecessor) |   |   | (Predecessor) |   |
|  Sales                                                                                                                                                             |   | $                               | 164,010 |   |   | $ | 124,223 |   |   | $ | 264,995 |   |
|  Cost of sales, including $7,474 of utilization of net increase in cost basis of inventory due to purchase accounting for period February 11, 2011 to July 1, 2011 |   |                            | 121,073 |   |   |   | 91,404 |   |   |   | 185,910 |   |
|  Gross profit                                                                                                                                                      |   |                            | 42,937  |   |   |   | 32,819 |   |   |   | 79,085 |   |
|  Operating costs and expenses:                                                                                                                                     |   |                            |    |   |   |   |   |   |   |   |   |   |
|  Research and development                                                                                                                                          |   |                            | 5,432   |   |   |   | 4,994 |   |   |   | 9,287 |   |
|  Selling and marketing                                                                                                                                             |   |                            | 8,002   |   |   |   | 8,264 |   |   |   | 15,392 |   |
|  General and administrative                                                                                                                                        |   |                            | 9,552   |   |   |   | 11,853 |   |   |   | 18,560 |   |
|  Amortization of acquisition-related intangible assets                                                                                                             |   |                            | 7,282   |   |   |   | 999 |   |   |   | 2,062 |   |
|  Strategic alternative transaction expenses                                                                                                                        |   |                            | 9,129   |   |   |   | 4,668 |   |   |   | 3,800 |   |
|  Total operating costs and expenses                                                                                                                                |   |                            | 39,397  |   |   |   | 30,778 |   |   |   | 49,101 |   |
|  Operating income                                                                                                                                                  |   |                            | 3,540   |   |   |   | 2,041 |   |   |   | 29,984 |   |
|  Interest expense, net                                                                                                                                             |   |                            | 10,949  |   |   |   | 5,788 |   |   |   | 11,516 |   |
|  Loss on debt extinguishment, net                                                                                                                                  |   |                            | 134     |   |   |   | - |   |   |   | - |   |
|  (Loss) income before income taxes                                                                                                                                 |   |                            | (7,543  | ) |   |   | (3,747 | ) |   |   | 18,468 |   |
|  Income tax expense                                                                                                                                                |   |                            | 1,462   |   |   |   | 983 |   |   |   | 5,924 |   |
|  Net (loss) income                                                                                                                                                 |   | $                               | (9,005  | ) |   | $ | (4,730 | ) |   | $ | 12,544 |   |
|                                                                                                                                                                    |   |                            |    |   |   |   |   |   |   |   |   |   |
|  Other comprehensive income  (loss), net of tax                                                                                                          |   |                            |    |   |   |   |   |   |   |   |   |   |
| Net unrealized gain (loss) on cash flow hedges and minimum pension liability adjustment                                                                            |   |                            | 225     |   |   |   | 459 |   |   |   | (92 | ) |
|  Comprehensive (loss) income                                                                                                                                       |   | $                               | (8,780  | ) |   | $ | (4,271 | ) |   | $ | 12,452 |   |

----

Table of Contents

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

|                                                                                         |   | Fiscal Year                     |     |
|----------------------------------------------------------------------------------------------|--------|---------------------------------|----------|
|                                                                                         |   | 2011                            |     |   | 2010 |   |
|                                                                                         |   | February 11, 2011toJuly 1, 2011 |     |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine MonthsEndedJuly 2, 2010 |   |
|                                                                                         |   | (Successor)                     |     |   | (Predecessor) |   |   | (Predecessor) |   |
| Cash flows from operating activities                                                         |   |                            |     |   |   |   |   |   |   |
| Net cash provided by operating activities                                                    |   | $                               | 7,340    |   |   | $ | 4,277 |   |   | $ | 22,516 |   |
|                                                                                         |   |                            |     |   |   |   |   |   |   |   |   |   |
| Cash flows from investing activities                                                         |   |                            |     |   |   |   |   |   |   |   |   |   |
| Capital expenditures                                                                         |   |                            | (2,483   | ) |   |   | (2,434 | ) |   |   | (2,824 | ) |
| Acquisition of predecessor entity                                                            |   |                            | (370,490 | ) |   |   | - |   |   |   | - |   |
| Payment of patent application fees                                                           |   |                            | -        |   |   |   | (6 | ) |   |   | (36 | ) |
| Net cash used in investing activities                                                        |   |                            | (372,973 | ) |   |   | (2,440 | ) |   |   | (2,860 | ) |
|                                                                                         |   |                            |     |   |   |   |   |   |   |   |   |   |
| Cash flows from financing activities                                                         |   |                            |     |   |   |   |   |   |   |   |   |   |
| Equity investment, net                                                                       |   |                            | 197,144  |   |   |   | - |   |   |   | - |   |
| Proceeds from issuance of Successor's senior subordinated notes                              |   |                            | 208,550  |   |   |   | - |   |   |   | - |   |
| Borrowings under Successor's term loan facility                                              |   |                            | 143,815  |   |   |   | - |   |   |   | - |   |
| Debt issue costs                                                                             |   |                            | (3,071   | ) |   |   | - |   |   |   | - |   |
| Redemption and repurchase of Predecessor's senior subordinated notes and floating rate notes |   |                            | (129,000 | ) |   |   | - |   |   |   | - |   |
| Repayment of borrowings under Predecessor's term loan facility                               |   |                            | (66,000  | ) |   |   | - |   |   |   | - |   |
| Repayment of borrowings under Successor's term loan facility                                 |   |                            | (750     | ) |   |   | - |   |   |   | - |   |
| Payment for Predecessor's senior credit facilities agreement amendment                       |   |                            | -        |   |   |   | (379 | ) |   |   | - |   |
| Proceeds from issuance of common stock to employees                                          |   |                            | -        |   |   |   | 217 |   |   |   | 579 |   |
| Proceeds from exercise of stock options                                                      |   |                            | -        |   |   |   | 174 |   |   |   | 214 |   |
| Excess tax benefit on stock option exercises                                                 |   |                            | -        |   |   |   | 2,191 |   |   |   | 582 |   |
| Net cash provided by financing activities                                                    |   |                            | 350,688  |   |   |   | 2,203 |   |   |   | 1,375 |   |
|                                                                                         |   |                            |     |   |   |   |   |   |   |   |   |   |
| Net (decrease) increase in cash and cash equivalents                                         |   |                            | (14,945  | ) |   |   | 4,040 |   |   |   | 21,031 |   |
| Cash and cash equivalents at beginning of period                                             |   |                            | 46,869   |   |   |   | 42,829 |   |   |   | 26,152 |   |
| Cash and cash equivalents at end of period                                                   |   | $                               | 31,924   |   |   | $ | 46,869 |   |   | $ | 47,183 |   |
|                                                                                         |   |                            |     |   |   |   |   |   |   |   |   |   |
| Supplemental cash flow disclosures                                                           |   |                            |     |   |   |   |   |   |   |   |   |   |
| Cash paid for interest                                                                       |   | $                               | 3,361    |   |   | $ | 6,451 |   |   | $ | 8,008 |   |
| Cash paid for income taxes, net of refunds                                                   |   | $                               | 56       |   |   | $ | 6,284 |   |   | $ | 8,069 |   |

----

Table of Contents

CPI INTERNATIONAL HOLDING CORP.

| 1.   | The Company and a Summary of its Significant Accounting Policies |
|----------------|------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

| 2.   | Recently Issued Accounting Standards |
|----------------|--------------------------------------|

----

Table of Contents

----

Table of Contents

----

Table of Contents

|                    |   | CPII shares |      |   | Preliminarypurchase price |    |
|-------------------------|--------|-------------|-----------|--------|---------------------------|---------|
| Common stock            |   | 16,742,279  |      |   | $                         | 326,474 |   |
| Restricted stock awards |   |        | 112,316   |   |                      |    | 930 |   |
| Restricted stock units  |   |        | 208,925   |   |                      |    | 1,194 |   |
| Stock options           |   |        | 3,354,222 |   |                      |    | 41,892 |   |
| Total                   |   |        |      |   |                      | $       | 370,490 |   |

| Preliminary purchase price                                                                                                               |   | $      | 370,490  |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|----------|--------|
| Less: Estimated fair value of assets acquired:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |   |   |     |   |
| Net current assets                                                                                                                                      |   |   | (111,439 | )      |
| Property, plant and equipment                                                                                                                           |   |   | (82,879  | )      |
| Identifiable intangible assets                                                                                                                          |   |   | (274,980 | )      |
| Other long-term assets                                                                                                                                  |   |   | (5,437   | )      |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |   |   | (474,735 | )      |
| Add: Estimated fair value of liabilities assumed:                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |   |   |     |   |
| Deferred tax liabilities                                                                                                                                |   |   | 85,366   |   |
| Long-term debt                                                                                                                                          |   |   | 195,487  |   |
| Other long-term liabilities                                                                                                                             |   |   | 4,533    |   |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |   |   | 285,386  |   |
| Goodwill                                                                                                                                 |   | $      | 181,141  |   |

----

Table of Contents

----

Table of Contents

|                                 |   | EstimatedFair Value |    |   | EstimatedUseful Life(years) |          |
|--------------------------------------|--------|---------------------|---------|--------|-----------------------------|---------------|
| Definite-lived assets:               |   |                |    |   |                        |          |
| Division tradenames                  |   | $                   | 2,900   |   |                        |  15      |   |
| Core technology                      |   |                | 94,400  |   |                        |  40      |   |
| Completed technology                 |   |                | 88,100  |   |                        |  15 - 25 |   |
| Backlog                              |   |                | 15,300  |   |                        |  1 - 2   |   |
| Leasehold interest                   |   |                | 35,680  |   |                        |  4 - 40  |   |
| Total definite-lived assets          |   |                | 236,380 |   |                        |          |   |   |
|                                 |   |                |    |   |                        |          |   |   |
| Indefinite-lived assets:             |   |                |    |   |                        |          |   |   |
| CPI tradenames                       |   |                | 35,100  |   |                        | Indefinite    |   |
| In-process research and development  |   |                | 3,500   |   |                        | Indefinite    |   |
| Total indefinite-lived assets        |   |                | 38,600  |   |                        |          |   |   |
|                                 |   |                |    |   |                        |          |   |   |
| Total identifiable intangible assets |   | $                   | 274,980 |   |                        |          |   |   |

----

Table of Contents

|              |   | Three Months Ended |    |   | Nine Months Ended |   |
|-------------------|--------|--------------------|---------|--------|-------------------|--------|
|              |   | July 1,2011        |    |   | July 2,2010       |   |   | July 1,2011 |   |   | July 2,2010 |   |
| Sales             |   | $                  | 104,206 |   |              | $      | 93,876 |   |   | $ | 288,233 |   |   | $ | 264,995 |   |
| Net income (loss) |   | $                  | 2,264   |   |              | $      | (641 | ) |   | $ | (845 | ) |   | $ | (1,887 | ) |

|                                  |   | July 1,     |   |   | October 1,    |   |
|---------------------------------------|--------|-------------|--------|--------|---------------|--------|
|                                  |   | 2011        |   |   | 2010          |   |
|                                  |   | (Successor) |   |   | (Predecessor) |   |
| Accounts receivable                   |   | $           | 44,828 |   |          | $      | 45,819 |   |
| Less: Allowance for doubtful accounts |   |        | -      |   |          |   | (112 | ) |
| Accounts receivable, net              |   | $           | 44,828 |   |          | $      | 45,707 |   |

----

Table of Contents

|                   |   | July 1,     |   |   | October 1,    |   |
|------------------------|--------|-------------|--------|--------|---------------|--------|
|                   |   | 2011        |   |   | 2010          |   |
|                   |   | (Successor) |   |   | (Predecessor) |   |
| Raw material and parts |   | $           | 45,732 |   |          | $      | 42,167 |   |
| Work in process        |   |        | 27,854 |   |          |   | 24,531 |   |
| Finished goods         |   |        | 9,351  |   |          |   | 8,510 |   |
|                   |   | $           | 82,937 |   |          | $      | 75,208 |   |

|                                                   |   | Fiscal Year                     |   |
|--------------------------------------------------------|--------|---------------------------------|--------|
|                                                   |   | 2011                            |   |   | 2010 |   |
|                                                   |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   | Nine Months EndedJuly 2, 2010 |   |
|                                                   |   | (Successor)                     |   |   | (Predecessor) |   |   | (Predecessor) |   |
| Balance at beginning of period                         |   | $                               | -      |   |   | $ | 3,737 |   |   | $ | 4,068 |   |
| Provision for loss contracts, charged to cost of sales |   |                            | 4,208  |   |   |   | 2,154 |   |   |   | 2,886 |   |
| Credit to cost of sales upon revenue recognition       |   |                            | (21    | ) |   |   | (2,982 | ) |   |   | (3,347 | ) |
| Balance at end of period                               |   | $                               | 4,187  |   |   | $ | 2,909 |   |   | $ | 3,607 |   |

|             |   | July 1,     |   |   | February 10,  |   |   | July 2,       |   |
|------------------|--------|-------------|--------|--------|---------------|--------|--------|---------------|--------|
|             |   | 2011        |   |   | 2011          |   |   | 2010          |   |
|             |   | (Successor) |   |   | (Predecessor) |   |   | (Predecessor) |   |
| Inventories      |   | $           | 2,911  |   |          | $      | 1,994  |          |   | $ | 3,468 |   |
| Accrued expenses |   |        | 1,276  |   |          |   | 915    |          |   |   | 139 |   |
|             |   | $           | 4,187  |   |          | $      | 2,909  |          |   | $ | 3,607 |   |

----

Table of Contents

|                                            |   | July 1,     |   |   | October 1,    |   |
|-------------------------------------------------|--------|-------------|--------|--------|---------------|--------|
|                                            |   | 2011        |   |   | 2010          |   |
|                                            |   | (Successor) |   |   | (Predecessor) |   |
| Land                                            |   | $           | 7,580  |   |          | $      | 2,947 |   |
| Land improvements                               |   |        | 2,225  |   |          |   | 1,861 |   |
| Buildings                                       |   |        | 38,410 |   |          |   | 41,424 |   |
| Machinery and equipment                         |   |        | 35,877 |   |          |   | 48,610 |   |
| Construction in progress                        |   |        | 1,059  |   |          |   | 1,023 |   |
|                                            |   |        | 85,151 |   |          |   | 95,865 |   |
| Less: accumulated depreciation and amortization |   |        | (3,498 | )      |          |   | (41,606 | ) |
| Property, plant and equipment, net              |   | $           | 81,653 |   |          | $      | 54,259 |   |

|                                |   | July 1, 2011                           |   |   | October 1, 2010 |   |
|-------------------------------------|--------|----------------------------------------|--------|--------|-----------------|--------|
|                                |   | (Successor)                            |   |   | (Predecessor)   |   |
|                                |   | Weighted Average Useful Life(in years) |   |   | Cost            |   |   | Accumulated Amortization |   |   | Net |   |   | Weighted Average Useful Life(in years) |   |   | Cost |   |   | Accumulated Amortization |   |   | Net |   |
| Definite-lived assets:              |   |                                   |   |   |            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Division tradenames                 |   |  15                               |   |   | $               | 2,900  |   |   |   | (73 | ) |   | $ | 2,827 |   |   |  20 |   |   | $ | 3,200 |   |   | $ | (495 | ) |   | $ | 2,705 |   |
| Core technology                     |   |  40                               |   |   |            | 94,400 |   |   |   | (885 | ) |   |   | 93,515 |   |   |  50 |   |   |   | 30,700 |   |   |   | (4,115 | ) |   |   | 26,585 |   |
| Completed technology                |   |  15 - 25                          |   |   |            | 88,100 |   |   |   | (1,769 | ) |   |   | 86,331 |   |   |  15 - 25 |   |   |   | 33,100 |   |   |   | (9,536 | ) |   |   | 23,564 |   |
| Backlog                             |   |  1 -2                             |   |   |            | 15,300 |   |   |   | (4,556 | ) |   |   | 10,744 |   |   |  1 |   |   |   | 580 |   |   |   | (580 | ) |   |   | - |   |
| Leasehold interest                  |   |  4 - 40                           |   |   |            | 35,680 |   |   |   | (367 | ) |   |   | 35,313 |   |   |  46 |   |   |   | 11,810 |   |   |   | (1,687 | ) |   |   | 10,123 |   |
| Customer list and programs          |   |                                   |   |   |            |   | - |   |   |   | - |   |   |   | - |   |   |  24 |   |   |   | 6,280 |   |   |   | (1,485 | ) |   |   | 4,795 |   |
| Noncompete agreement                |   |                                   |   |   |            |   | - |   |   |   | - |   |   |   | - |   |   |  5 |   |   |   | 530 |   |   |   | (332 | ) |   |   | 198 |   |
| Patent application fees             |   |                                   |   |   |            |   | - |   |   |   | - |   |   |   | - |   |   |  - |   |   |   | 104 |   |   |   | - |   |   |   | 104 |   |
| Total definite-lived assets         |   |                                   |   |   |            |   | 236,380 |   |   |   | (7,650 | ) |   |   | 228,730 |   |   |   |   |   |   |   | 86,304 |   |   |   | (18,230 | ) |   |   | 68,074 |   |
|                                |   |                                   |   |   |            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Indefinite-lived assets:            |   |                                   |   |   |            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| CPI tradenames                      |   |                                   |   |   |            |   | 35,100 |   |   |   | - |   |   |   | 35,100 |   |   |   |   |   |   |   | 4,400 |   |   |   | - |   |   |   | 4,400 |   |
| In-process research and development |   |                                   |   |   |            |   | 3,500 |   |   |   | - |   |   |   | 3,500 |   |   |   |   |   |   |   | - |   |   |   | - |   |   |   | - |   |
| Total indefinite-lived assets       |   |                                   |   |   |            |   | 38,600 |   |   |   | - |   |   |   | 38,600 |   |   |   |   |   |   |   | 4,400 |   |   |   | - |   |   |   | 4,400 |   |
|                                |   |                                   |   |   |            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Total intangible assets             |   |                                   |   |   |            | $      | 274,980 |   |   | $ | (7,650 | ) |   | $ | 267,330 |   |   |   |   |   |   | $ | 90,704 |   |   | $ | (18,230 | ) |   | $ | 72,474 |   |

----

Table of Contents

| Fiscal Year                   |   | Amount |    |
|-------------------------------|--------|--------|---------|
| 2011 (remaining three months) |   | $      | 5,101   |   |
| 2012                          |   |   | 14,776  |   |
| 2013                          |   |   | 9,431   |   |
| 2014                          |   |   | 8,250   |   |
| 2015                          |   |   | 8,232   |   |
| Thereafter                    |   |   | 182,940 |   |
|                          |   | $      | 228,730 |   |

|                   |   | July 1,     |    |   | October 1,    |   |
|------------------------|--------|-------------|---------|--------|---------------|--------|
|                   |   | 2011        |    |   | 2010          |   |
|                   |   | (Successor) |    |   | (Predecessor) |   |
|  VED              |   | $           | 130,254 |   |          | $      | 132,621 |   |
|  Satcom equipment |   |        | 39,252  |   |          |   | 13,720 |   |
|  Other            |   |        | 11,635  |   |          |   | 15,884 |   |
|                   |   | $           | 181,141 |   |          | $      | 162,225 |   |

|                                                     |   | Fiscal Year                     |   |
|----------------------------------------------------------|--------|---------------------------------|--------|
|                                                     |   | 2011                            |   |   | 2010 |   |
|                                                     |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   | Nine MonthsEndedJuly 2, 2010 |   |
|                                                     |   | (Successor)                     |   |   | (Predecessor) |   |   | (Predecessor) |   |
| Beginning accrued warranty                               |   | $                               | 5,490  |   |   | $ | 5,101 |   |   | $ | 3,845 |   |
| Actual costs of warranty claims                          |   |                            | (1,934 | ) |   |   | (2,020 | ) |   |   | (4,087 | ) |
| Estimates for product warranty, charged to cost of sales |   |                            | 1,908  |   |   |   | 2,409 |   |   |   | 5,072 |   |
| Ending accrued warranty                                  |   | $                               | 5,464  |   |   | $ | 5,490 |   |   | $ | 4,830 |   |

----

Table of Contents

|                                                                                 |   | July 1,     |   |   | October 1,    |   |
|--------------------------------------------------------------------------------------|--------|-------------|--------|--------|---------------|--------|
|                                                                                 |   | 2011        |   |   | 2010          |   |
|                                                                                 |   | (Successor) |   |   | (Predecessor) |   |
| Unrealized gain on cash flow hedges, net of tax                                      |   | $           | 225    |   |          | $      | 175 |   |
| Unrealized actuarial loss and prior service credit for pension liability, net of tax |   |        | -      |   |          |   | (316 | ) |
| Accumulated other comprehensive income (loss)                                        |   | $           | 225    |   |          | $      | (141 | ) |

----

Table of Contents

|                                                   |   |   |   |   | Successor                                            |   |
|--------------------------------------------------------|--------|--------|--------|--------|------------------------------------------------------|--------|
|                                                   |   |   |   |   | Fair Value Measurements at July 1, 2011 Using        |   |
|                                                   |   |   |   |   | Quoted Prices in Active Markets for Identical Assets |   |   | Significant Other Observable Inputs |   |   | Significant Unobservable Inputs |   |
|                                                   |   | Total  |   |   | (Level 1)                                            |   |   | (Level 2) |   |   | (Level 3) |   |
| Assets:                                                |   |   |   |   |                                                 |   |   |   |   |   |   |   |
| Money market and overnight U.S. Government securities1 |   | $      | 29,979 |   |                                                 | $      | 29,979 |   |   | $ | - |   |   | $ | - |   |
| Mutual funds2                                          |   |   | 196    |   |                                                 |   | 196 |   |   |   | - |   |   |   | - |   |
| Foreign exchange forward derivatives3                  |   |   | 472    |   |                                                 |   | - |   |   |   | 472 |   |   |   | - |   |
| Total assets at fair value                             |   | $      | 30,647 |   |                                                 | $      | 30,175 |   |   | $ | 472 |   |   |   | - |   |

|   |   |   |   |
|--------|--------|--------|--------|

| 1 The money market and overnight U.S. Government securities are classified as part of cash and cash equivalents and restricted cash in the condensed consolidated balance sheet. |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| 2 The mutual funds are classified as part of other long-term assets in the condensed consolidated balance sheet.                                                                 |   |
| 3 The foreign currency derivatives are classified as part of prepaid and other current assets in the condensed consolidated balance sheet.                                       |   |

----

Table of Contents

|                                                   |   |   |   |  Predecessor                                    |   |
|--------------------------------------------------------|--------|--------|--------|------------------------------------------------------|--------|
|                                                   |   |   |   | Fair Value Measurements at October 1, 2010 Using     |   |
|                                                   |   |   |   | Quoted Prices in Active Markets for Identical Assets |   |   | Significant Other Observable Inputs |   |   | Significant Unobservable Inputs |   |
|                                                   |   | Total  |   | (Level 1)                                            |   |   | (Level 2) |   |   | (Level 3) |   |
| Assets:                                                |   |   |   |                                                 |   |   |   |   |   |   |   |
| Money market and overnight U.S. Government securities1 |   | $      | 36,420 |                                                 | $      | 36,420 |   |   | $ | - |   |   | $ | - |   |
| Mutual funds2                                          |   |   | 171    |                                                 |   | 171 |   |   |   | - |   |   |   | - |   |
| Foreign exchange forward derivatives3                  |   |   | 437    |                                                 |   | - |   |   |   | 437 |   |   |   | - |   |
| Total assets at fair value                             |   | $      | 37,028 |                                                 | $      | 36,591 |   |   | $ | 437 |   |   |   | - |   |
|                                                   |   |   |   |                                                 |   |   |   |   |   |   |   |   |   |   |   |
| Liabilities:                                           |   |   |   |                                                 |   |   |   |   |   |   |   |   |   |   |   |
| Interest rate swap derivative4                         |   | $      | 816    |                                                 | $      | - |   |   | $ | 816 |   |   | $ | - |   |
| Total liabilities at fair value                        |   | $      | 816    |                                                 | $      | - |   |   | $ | 816 |   |   | $ | - |   |

|                                                                                                                                                                             |   |   |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|
| 1 The money market and overnight U.S. Government securities are classified as part of cash and cash equivalents and restricted cash in the condensed consolidated balance sheet. |
| 2 The mutual funds are classified as part of other long-term assets in the condensed consolidated balance sheet.                                                                 |
| 3 The foreign currency derivatives are classified as part of prepaid and other current assets in the condensed consolidated balance sheet.                                       |
| 4 The interest rate swap derivatives are classified as part of accrued expenses in the condensed consolidated balance sheet.                                                     |

----

Table of Contents

----

Table of Contents

|                                                             |   | July 1,     |    |   | October 1,    |   |
|------------------------------------------------------------------|--------|-------------|---------|--------|---------------|--------|
|                                                             |   | 2011        |    |   | 2010          |   |
|                                                             |   | (Successor) |    |   | (Predecessor) |   |
| Term loan, net of issue discount of $707 and $0                  |   | $           | 148,543 |   |          | $      | 66,000 |   |
| 8% Senior subordinated notes due 2012                            |   |        | -       |   |          |   | 117,000 |   |
| 8% Senior notes due 2018                                         |   |        | 215,000 |   |          |   | - |   |
| Floating rate senior notes due 2015, net f issue discount of $66 |   |        | -       |   |          |   | 11,934 |   |
|                                                             |   |        | 363,543 |   |          |   | 194,934 |   |
| Less:  Current portion                                 |   |        | 1,500   |   |          |   | 66,000 |   |
| Long-term portion                                                |   | $           | 362,043 |   |          | $      | 128,934 |   |
|                                                             |   |        |    |   |          |   |   |   |
| Standby letters of credit                                        |   | $           | 3,935   |   |          | $      | 4,544 |   |

----

Table of Contents

| ·   | 100% of the net cash proceeds received from the sale or other disposition of all or any part of the assets of the Parent or any of its restricted subsidiaries in excess of $15.0 million, other than sales of inventory in the ordinary course of business and other than amounts reinvested in assets to be used in CPII’s business within 12 months of such disposition (or if committed to be reinvested within such 12 months, reinvested within 18 months of such disposition) and subject to other exceptions; |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | 100% of the net proceeds received by the Parent or any of its restricted subsidiaries from the issuance of debt or disqualified preferred stock after the Closing Date, other than debt permitted under the Senior Credit Facilities; |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | 100% of all casualty and condemnation proceeds received by the Parent or any of its restricted subsidiaries in excess of $15.0 million, other than amounts reinvested in assets to be used in CPII’s business within 12 months of such receipt (or if committed to be reinvested within such 12 months, reinvested within 18 months of such receipt) and subject to other exceptions; and |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | 50% of excess cash flow of the Parent and its restricted subsidiaries, such percentage to be reduced based on the Parent attaining certain leverage ratios. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| ·   | dispose of assets and make changes in business; |
|--------------------|-------------------------------------------------|

| ·   | incur additional indebtedness or issue preferred stock or prepay, amend or redeem certain indebtedness; |
|--------------------|---------------------------------------------------------------------------------------------------------|

| ·   | create liens on assets and make further negative pledges; |
|--------------------|-----------------------------------------------------------|

| ·   | enter into sale and leaseback transactions; |
|--------------------|---------------------------------------------|

| ·   | engage in mergers or acquisitions; |
|--------------------|------------------------------------|

| ·   | pay dividends or distributions or repurchase or redeem capital stock or make other restricted payments; |
|--------------------|---------------------------------------------------------------------------------------------------------|

| ·   | make investments, loans or advances; |
|--------------------|--------------------------------------|

| ·   | make capital expenditures; |
|--------------------|----------------------------|

| ·   | engage in certain transactions with affiliates; |
|--------------------|-------------------------------------------------|

| ·   | amend charter documents and material agreements in a manner adverse in any material respect to the lenders without their consent; |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------|

| ·   | change accounting polices; |
|--------------------|----------------------------|

| ·   | permit certain restrictions affecting subsidiaries; and |
|--------------------|---------------------------------------------------------|

| ·   | change the status of Parent as a holding company. |
|--------------------|---------------------------------------------------|

----

Table of Contents

|  Year          |   | Optional Redemption Price |   |
|---------------------|--------|---------------------------|--------|
| 2015                |   |                      | 104    | % |
| 2016                |   |                      | 102    | % |
| 2017 and thereafter |   |                      | 100    | % |

----

Table of Contents

| Fiscal Year                   |   | TermLoan |    |   | 8% SeniorNotes |   |    | Total  |   |
|-------------------------------|--------|----------|---------|--------|----------------|--------|---------|--------|--------|
| 2011 (remaining three months) |   | $        | 375     |   |           | $      | -       |   |   | $ | 375 |   |
| 2012                          |   |     | 1,500   |   |           |   | -       |   |   |   | 1,500 |   |
| 2013                          |   |     | 1,500   |   |           |   | -       |   |   |   | 1,500 |   |
| 2014                          |   |     | 1,500   |   |           |   | -       |   |   |   | 1,500 |   |
| 2015                          |   |     | 1,500   |   |           |   | -       |   |   |   | 1,500 |   |
| Thereafter                    |   |     | 142,875 |   |           |   | 215,000 |   |   |   | 357,875 |   |
|                          |   | $        | 149,250 |   |           | $      | 215,000 |   |   | $ | 364,250 |   |

----

Table of Contents

----

Table of Contents

|                                                  | Asset Derivatives                |   | Liability Derivatives  |   |
|-------------------------------------------------------|----------------------------------|--------|------------------------|--------|
|                                                  |                             |   | Fair Value             |   |   |   | Fair Value |   |
|                                                  | Balance Sheet Location           |   | July 1,2011(Successor) |   |   | October 1,2010(Predecessor) |   | Balance Sheet Location |   | July 1,2011(Successor) |   |   | October 1,2010(Predecessor) |   |
| Derivatives designated as hedging instruments         |                             |   |                   |   |   |   |   |   |   |   |   |   |   |   |
|      Interest rate contracts |                             |   |                   |   |   |   |   | Accrued expenses |   | $ | - |   |   | $ | 816 |   |
|                                                  |                             |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|      Forward contracts       | Prepaid and other current assets |   | $                      | 472    |   |   | $ | 437 |   |   |   |   |   |   |   |   |   |   |
| Total derivatives designated as hedging instruments   |                             | $      | 472                    |   |   | $ | 437 |   |   |   | $ | - |   |   | $ | 816 |   |

----

Table of Contents

|   Derivatives in Cash Flow Hedging Relationships |   | Amount ofGain (Loss) Recognized in OCI on Derivative(Effective Portion) |   | Location ofGain (Loss) Reclassified from Accumulated OCI into Income(Effective Portion) |          | Amount ofGain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) |   |  Location ofGain (Loss) Recognized in Income on Derivative (Ineffective and Excluded Portion) |                             |   Amount of Gain (Loss) Recognized in Income on Derivative(Ineffective and Excluded Portion ) |   |
|-------------------------------------------------------|--------|------------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------|---------------|----------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------------------|----------------------------------|----------------------------------------------------------------------------------------------------|--------|
|                                                  |   | Three Months Ended                                                           |   |                                                                                    |          | Three Months Ended                                                                     |   |                                                                                                    |                             | Three Months Ended                                                                                 |   |
|                                                  |   | July 1, 2011                                                                 |   |                                                                                    | July 2, 2010  |                                                                                   |   |                                                                                                    | July 1, 2011                     |                                                                                               |   | July 2, 2010 |   |   |   | July 1, 2011 |   |   | July 2, 2010 |   |
|                                                  |   |  (Successor)                                                            |   |                                                                                    | (Predecessor) |                                                                                   |   |                                                                                                    | (Successor)                      |                                                                                               |   | (Predecessor) |   |   |   | (Successor) |   |   | (Predecessor) |   |
|  Interest rate contracts                         |   | $                                                                            | -      |                                                                                    |          | $                                                                                      | (33    | )                                                                                                       |  Interest expense, net      |                                                                                               | $      | - |   |   | $ | (443 | ) |  Interest expense, net |   | $ | - |   |   | $ | (9 | ) |
|                                                  |   |                                                                         |   |                                                                                    |          |                                                                                   |   |                                                                                                    |                             |                                                                                               |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|  Forward contracts                               |   |                                                                         | 129    |                                                                                    |          |                                                                                   | (667   | )                                                                                                       |  Cost of sales              |                                                                                               |   | 67 |   |   |   | 1,199 |   |  General and administrative(a) | 64 |   |   |   | 3 |   |
|                                                  |   |                                                                         |   |                                                                                    |          |                                                                                   |   |                                                                                                    |  Research and development   |                                                                                               | 35     |   |   |   | 149 |   |   |   |   |   |   |   |   |   |   |
|                                                  |   |                                                                         |   |                                                                                    |          |                                                                                   |   |                                                                                                    |  Selling and marketing      |                                                                                               |   | 16 |   |   |   | 65 |   |   |   |   |   |   |   |   |   |   |
|                                                  |   |                                                                         |   |                                                                                    |          |                                                                                   |   |                                                                                                    |  General and administrative |                                                                                               | 20     |   |   |   | 94 |   |   |   |   |   |   |   |   |   |   |
|  Total                                           |   | $                                                                            | 129    |                                                                                    |          | $                                                                                      | (700   | )                                                                                                       |                             |                                                                                               | $      | 138 |   |   | $ | 1,64 |   |   |   | $ | 64 |   |   | $ | (6 | ) |

|   |   |
|--------|--------|

| (a) The amount of gain recognized in income during the first quarter of fiscal year 2011 represents a $33 gain related to the amount excluded from the assessment of hedge effectiveness. The amount of gain recognized in income during the first quarter of fiscal year 2010 represents a $5 gain related to the ineffective portion of the hedging relationships, net of a $3 loss related to the amount excluded from the assessment of hedge effectiveness. |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Derivatives in Cash Flow Hedging Relationships |   | Amount of Gain (Loss) Recognized in OCI on Derivative(Effective Portion) |   | Location of Gain (Loss) Reclassified from AccumulatedOCI into Income(Effective Portion) |                               | Amount of Gain (Loss) Reclassified from Accumulated OCI into Income(Effective Portion) |                         | Location of Gain (Loss) Recognized in Income on Derivative (Ineffective and Excluded Portion) |   | Amount of Gain (Loss) Recognized in Income on Derivative(Ineffective and Excluded Portion ) |                            |
|------------------------------------------------|--------|--------------------------------------------------------------------------|--------|-----------------------------------------------------------------------------------------|------------------------------------|---------------------------------------------------------------------------------------------|------------------------------|-----------------------------------------------------------------------------------------------|--------|---------------------------------------------------------------------------------------------|---------------------------------|
|                                           |   | Fiscal Year                                                              |   |                                                                                    |                               | Fiscal Year                                                                                 |                         |                                                                                          |   |   Fiscal Year                                                                          |                            |
|                                           |   | 2011                                                                     |   | 2010                                                                                    |                               |                                                                                        |                         | 2011                                                                                          |   | 2010                                                                                        |                            |   |   | 2011 |   |  2010 |   |
|                                           |   | February 11, 2011toJuly 1, 2011                                          |   |                                                                                    | October 2, 2010toFebruary 10, 2011 |                                                                                        | Nine MonthsEndedJuly 2, 2010 |                                                                                          |   |                                                                                        | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   | Nine MonthsEndedJuly 2, 2010 |   |   |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   |  Nine MonthsEndedJuly 2, 2010 |   |
|                                           |   | (Successor)                                                              |   |                                                                                    | (Predecessor)                      |                                                                                        |  (Predecessor)          |                                                                                          |   |                                                                                        | (Successor)                     |   |   | (Predecessor) |   | (Predecessor) |   |   |   | (Successor) |   |   | (Predecessor) |   | (Predecessor) |   |
|  Interest rate contracts                  |   | $                                                                        | -      |                                                                                    |                               | $                                                                                           | 360                          |                                                                                          | $      | (281                                                                                        | )                               |  Interest expense, net |   | $ | - |   |   | $ | (456 | )  | $ | (1,495 | ) |  Interest expense, net(b) |   | $ | - |   |   | $ | (424 | )  | $ | (28 | ) |
|                                           |   |                                                                     |   |                                                                                    |                               |                                                                                        |                         |                                                                                          |   |                                                                                        |                            |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|  Forward contracts                        |   |                                                                     | 497    |                                                                                    |                               |                                                                                        | 463                          |                                                                                          |   | 888                                                                                         |                            |  Cost of sales |   |   | 67 |   |   |   | 614 |   |   | 1,805 |   |  General and administrative(c) |   |   | 106 |   |   |   | 50 |   |   | 51 |   |
|                                           |   |                                                                     |   |                                                                                    |                               |                                                                                        |                         |                                                                                          |   |                                                                                        |                            |  Research and development |   |   | 41 |   |   |   | 71 |   |   | 307 |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                           |   |                                                                     |   |                                                                                    |                               |                                                                                        |                         |                                                                                          |   |                                                                                        |                            |  Selling and marketing |   |   | 18 |   |   |   | 31 |   |   | 134 |   |   |   |   |   |   |   |   |   |   |   |   |   |
|                                           |   |                                                                     |   |                                                                                    |                               |                                                                                        |                         |                                                                                          |   |                                                                                        |                            |  General and administrative |   |   | 23 |   |   |   | 42 |   |   | 185 |   |   |   |   |   |   |   |   |   |   |   |   |   |
|  Total                                    |   | $                                                                        | 497    |                                                                                    |                               | $                                                                                           | 823                          |                                                                                          | $      | 607                                                                                         |                            |   |   | $ | 149 |   |   | $ | 302 |   | $ | 936 |   |   |   | $ | 106 |   |   | $ | (374 |   | $ | 23 |   |

|   |   |
|--------|--------|

| (b) The amount of loss recognized in income during the period October 2, 2010 to February 10, 2011 includes a $415 loss related to the ineffective portion of the hedging relationships as a result of early termination of the derivative.                                                                                                                                                                                                                                                 |   |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|
| (c) The amount of gain recognized in income during the periods of fiscal year 2011 presented represents a $106 and $50 gain, respectively, related to the amount excluded from the assessment of hedge effectiveness. The amount of gain recognized in income during the nine months ended July 2, 2010 represents a $62 gain related to the ineffective portion of the hedging relationships, net of a $11 loss related to the amount excluded from the assessment of hedge effectiveness. |   |

----

Table of Contents

----

Table of Contents

----

Table of Contents

----

Table of Contents

|                                                                          |   | Three MonthsEndedJuly 1, 2011 |   |   | February 11, 2011toJuly 1, 2011 |   |
|-------------------------------------------------------------------------------|--------|-------------------------------|--------|--------|---------------------------------|--------|
| Equity-based compensation cost recognized in the income statement by caption: |   |                          |   |   |                            |   |
| Research and development                                                      |   | $                             | 8      |   |                            | $      | 8 |   |
| Selling and marketing                                                         |   |                          | 23     |   |                            |   | 23 |   |
| General and administrative                                                    |   |                          | 99     |   |                            |   | 99 |   |
|                                                                          |   | $                             | 130    |   |                            | $      | 130 |   |
|                                                                          |   |                          |   |   |                            |   |   |   |
| Equity-based compensation cost capitalized in inventory                       |   | $                             | 46     |   |                            | $      | 46 |   |
| Equity-based compensation cost remaining in inventory at end of period        |   | $                             | 46     |   |                            | $      | 46 |   |

| Fiscal Year                   |   | Amount |   |
|-------------------------------|--------|--------|--------|
| 2011 (remaining three months) |   | $      | 244    |   |
| 2012                          |   |   | 969    |   |
| 2013                          |   |   | 970    |   |
| 2014                          |   |   | 970    |   |
| 2015                          |   |   | 970    |   |
| Thereafter                    |   |   | 622    |   |
|                          |   | $      | 4,745  |   |

----

Table of Contents

|                                                             |   | Oustanding Options |       |   | Exercisable Options             |   |
|------------------------------------------------------------------|--------|--------------------|------------|--------|---------------------------------|--------|
|                                                             |   | Number of Shares   |       |   | Weighted-Average Exercise Price |   |   | Weighted-Average Remaining Contractual Term (Years) |   |   | Aggregate Intrinsic Value |   |   | Number of Shares |   |   | Weighted-Average Exercise Price |   |   | Weighted-Average Remaining Contractual Term (Years) |   |   | Aggregate Intrinsic Value |   |
| Balance at October 1, 2010                                       |   |               | 3,347,192  |   |                            | $      | 6.60 |   |   |   | 4.24 |   |   | $ | 26,801 |   |   |   | 2,915,483 |   |   | $ | 5.61 |   |   |   | 3.76 |   |   | $ | 25,930 |   |
| Granted                                                          |   |               | 108,000    |   |                            |   | 19.33 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Exercised                                                        |   |               | (19,970    | )      |                            |   | 8.69 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Accelerated, cancelled and paid with cash pursuant to the Merger |   |               | (3,354,222 | )      |                            |   | 6.69 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Cancelled                                                        |   |               | (81,000    | )      |                            |   | 19.33 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Balance at February 11, 2011                                     |   |               | -          |   |                            |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |   |   | - |   |

----

Table of Contents

|                               |   | Number of Shares |     |   | Weighted-Average Grant-Date Fair Value Per Share |   |
|------------------------------------|--------|------------------|----------|--------|--------------------------------------------------|--------|
| Nonvested at October 1, 2010       |   |             | 310,341  |   |                                             | $      | 10.51 |   |
| Granted                            |   |             | 138,700  |   |                                             | $      | 19.33 |   |
| Vested                             |   |             | (23,775  | )      |                                             | $      | 15.18 |   |
| Accelerated pursuant to the Merger |   |             | (321,241 | )      |                                             | $      | 11.12 |   |
| Cancelled                          |   |             | (104,025 | )      |                                             | $      | 19.33 |   |
| Nonvested at February 11, 2011     |   |             | -        |   |                                             |   | - |   |

|                     |   | Fiscal Year                        |   |
|--------------------------|--------|------------------------------------|--------|
|                     |   | 2011                               |   |   | 2010 |   |
|                     |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine Months EndedJuly 2, 2010 |   |
|                     |   | (Predecessor)                      |   |   | (Predecessor) |   |
| Expected term (in years) |   |                               | 8.14   |   |   |   | 7.79 |   |
| Expected volatility      |   |                               | 60.91  | % |   |   | 60.50 | % |
| Risk-free rate           |   |                               | 2.57   | % |   |   | 3.00 | % |
| Dividend yield           |   |                               | 0      | % |   |   | 0 | % |

----

Table of Contents

|                                                                         |   | Fiscal Year                       |   |
|------------------------------------------------------------------------------|--------|-----------------------------------|--------|
|                                                                         |   | 2011                              |   |   | 2010 |   |   | 2011 |   |   | 2010 |   |
|                                                                         |   | Three MonthsEndedJuly 1, 2011 (a) |   |   | Three MonthsEndedJuly 2, 2010 |   |   | February 11, 2011toJuly 1, 2011 (a) |   |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine MonthsEndedJuly 2, 2010 |   |
|                                                                         |   | (Successor)                       |   |   | (Predecessor) |   |   | (Successor) |   |   | (Predecessor) |   |   | (Predecessor) |   |
| Share-based compensation cost recognized in the income statement by caption: |   |                              |   |   |   |   |   |   |   |   |   |   |   |
| Cost of sales                                                                |   | $                                 | 104    |   |   | $ | 152 |   |   | $ | 416 |   |   | $ | 609 |   |   | $ | 432 |   |
| Research and development                                                     |   |                              | -      |   |   |   | 51 |   |   |   | - |   |   |   | 320 |   |   |   | 161 |   |
| Selling and marketing                                                        |   |                              | -      |   |   |   | 74 |   |   |   | - |   |   |   | 499 |   |   |   | 214 |   |
| General and administrative                                                   |   |                              | -      |   |   |   | 505 |   |   |   | - |   |   |   | 3,127 |   |   |   | 1,493 |   |
|                                                                         |   | $                                 | 104    |   |   | $ | 782 |   |   | $ | 416 |   |   | $ | 4,555 |   |   | $ | 2,300 |   |
|                                                                         |   |                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Share-based compensation cost capitalized in inventory                       |   | $                                 | -      |   |   | $ | 153 |   |   | $ | - |   |   | $ | 928 |   |   | $ | 444 |   |
| Share-based compensation cost remaining in inventory at end of period        |   | $                                 | -      |   |   | $ | 98 |   |   | $ | - |   |   | $ | 416 |   |   | $ | 98 |   |
|                                                                         |   |                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Share-based compensation expense by type of award:                           |   |                              |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Stock options                                                                |   | $                                 | 23     |   |   | $ | 460 |   |   | $ | 90 |   |   | $ | 1,564 |   |   | $ | 1,375 |   |
| Restricted stock and units                                                   |   |                              | 81     |   |   |   | 286 |   |   |   | 326 |   |   |   | 2,948 |   |   |   | 823 |   |
| Stock purchase plan                                                          |   |                              | -      |   |   |   | 36 |   |   |   | - |   |   |   | 43 |   |   |   | 102 |   |
|                                                                         |   | $                                 | 104    |   |   | $ | 782 |   |   | $ | 416 |   |   | $ | 4,555 |   |   | $ | 2,300 |   |
|                                                                         |   |                              |

| (a)   | Stock-based compensation expense of $104 and $416 for the three months ended July 1, 2011 and the period February 11, 2011 to July 1, 2011 represents utilization of the share-based compensation cost in inventory at February 10, 2011. |
|-----------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                              |   | February 11, 2011toJuly 1, 2011      |   | October 2, 2010toFebruary 10, 2011 |                           | Nine Months endedJuly 2, 2010 |   |
|-----------------------------------|--------|--------------------------------------|--------|------------------------------------|--------------------------------|-------------------------------|--------|
| Year-to-Date                      |   | (Successor)                          |   |                               | (Predecessor)                  |                          |   | (Predecessor) |   |
| (Loss) income before income taxes |   | $                                    | (7,543 | )                                  |                           | $                             | (3,747 | ) |   | $ | 18,468 |   |
| Income tax expense                |   | $                                    | 1,462  |                               |                           | $                             | 983    |   |   | $ | 5,924 |   |
| Effective income tax rate         |   |                                 | (19.4  | %)                                 |                           |                          | (26.2  | %) |   |   | 32.1 | % |
|                              |
|                              |   |  Three Months EndedJuly 1, 2011 |   |                               | Three Months EndedJuly 2, 2010 |                          |   |   |   |   |
| Third Quarter                     |   | (Successor)                          |   |                               | (Predecessor)                  |                          |   |   |   |   |
| Income before income taxes        |   | $                                    | 125    |                               |                           | $                             | 5,773  |   |   |   |   |   |
| Income tax expense                |   | $                                    | 1,957  |                               |                           | $                             | 1,562  |   |   |   |   |   |
| Effective income tax rate         |   |                                 | 1565.6 | %                                  |                           |                          | 27.1   | % |   |   |   |   |

----

Table of Contents

|                                     |   | Fiscal Year                   |    |
|------------------------------------------|--------|-------------------------------|---------|
|                                     |   | 2011                          |    |   | 2010 |   |   | 2011 |   |   | 2010 |   |
|                                     |   | Three MonthsEndedJuly 1, 2011 |    |   | Three MonthsEndedJuly 2, 2010 |   |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine MonthsEndedJuly 2, 2010 |   |
|                                     |   | (Successor)                   |    |   | (Predecessor) |   |   | (Successor) |   |   | (Predecessor) |   |   | (Predecessor) |   |
|  Sales from external customers      |   |                          |    |   |   |   |   |   |   |   |   |   |   |   |   |
|     VED              |   | $                             | 64,109  |   |   | $ | 66,701 |   |   | $ | 105,362 |   |   | $ | 89,174 |   |   | $ | 191,006 |   |
|     Satcom equipment |   |                          | 35,204  |   |   |   | 21,621 |   |   |   | 49,901 |   |   |   | 27,469 |   |   |   | 62,666 |   |
|     Other            |   |                          | 4,893   |   |   |   | 5,554 |   |   |   | 8,747 |   |   |   | 7,580 |   |   |   | 11,323 |   |
|                                     |   | $                             | 104,206 |   |   | $ | 93,876 |   |   | $ | 164,010 |   |   | $ | 124,223 |   |   | $ | 264,995 |   |
|  Intersegment product transfers     |   |                          |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|     VED              |   | $                             | 9,513   |   |   | $ | 5,853 |   |   | $ | 14,873 |   |   | $ | 8,045 |   |   | $ | 18,257 |   |
|     Satcom equipment |   |                          | -       |   |   |   | 94 |   |   |   | 45 |   |   |   | 229 |   |   |   | 95 |   |
|                                     |   | $                             | 9,513   |   |   | $ | 5,947 |   |   | $ | 14,918 |   |   | $ | 8,274 |   |   | $ | 18,352 |   |
|  Capital expenditures               |   |                          |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|     VED              |   | $                             | 1,164   |   |   | $ | 704 |   |   | $ | 1,824 |   |   | $ | 1,484 |   |   | $ | 1,974 |   |
|     Satcom equipment |   |                          | 277     |   |   |   | 120 |   |   |   | 555 |   |   |   | 694 |   |   |   | 346 |   |
|     Other            |   |                          | 85      |   |   |   | 165 |   |   |   | 104 |   |   |   | 256 |   |   |   | 504 |   |
|                                     |   | $                             | 1,526   |   |   | $ | 989 |   |   | $ | 2,483 |   |   | $ | 2,434 |   |   | $ | 2,824 |   |
|  EBITDA                             |   |                          |    |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
|     VED              |   | $                             | 17,228  |   |   | $ | 17,744 |   |   | $ | 29,806 |   |   | $ | 18,713 |   |   | $ | 47,862 |   |
|     Satcom equipment |   |                          | 6,404   |   |   |   | 1,737 |   |   |   | 8,351 |   |   |   | 1,491 |   |   |   | 6,455 |   |
|     Other            |   |                          | (9,258  | ) |   |   | (7,160 | ) |   |   | (23,642 | ) |   |   | (14,046 | ) |   |   | (16,080 | ) |
|                                     |   | $                             | 14,374  |   |   | $ | 12,321 |   |   | $ | 14,515 |   |   | $ | 6,158 |   |   | $ | 38,237 |   |

|                                     |   | July 1,     |    |   | October 1,    |   |
|------------------------------------------|--------|-------------|---------|--------|---------------|--------|
|                                     |   | 2011        |    |   | 2010          |   |
|                                     |   | (Successor) |    |   | (Predecessor) |   |
|  Total assets                       |   |        |    |   |          |   |
|     VED              |   | $           | 487,677 |   |          | $      | 326,117 |   |
|     Satcom equipment |   |        | 122,236 |   |          |   | 48,355 |   |
|     Other            |   |        | 117,557 |   |          |   | 103,804 |   |
|                                     |   | $           | 727,470 |   |          | $      | 478,276 |   |

----

Table of Contents

|   | • | EBITDA is a component of the measures used by the Company’s board of directors and management team to evaluate the Company’s operating performance; |
|--------|---------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the Company’s Senior Secured Credit Facilities contain a covenant that requires the Company to maintain a total leverage ratio that contains EBITDA as a component, and the Company’s management team uses EBITDA to monitor compliance with this covenant; |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | EBITDA is a component of the measures used by the Company’s management team to make day-to-day operating decisions; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------|

|   | • | EBITDA facilitates comparisons between the Company’s operating results and those of competitors with different capital structures and, therefore, is a component of the measures used by the Company’s management to facilitate internal comparisons to competitors’ results and the Company’s industry in general; and |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the payment of management bonuses is contingent upon, among other things, the satisfaction by the Company of certain targets that contain EBITDA as a component. |
|--------|---------|------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                   |   | Fiscal Year                   |    |
|------------------------|--------|-------------------------------|---------|
|                   |   | 2011                          |    |   | 2010 |   |   | 2011 |   | 2010 |   |
|                   |   | Three MonthsEndedJuly 1, 2011 |    |   | Three MonthsEndedJuly 2, 2010 |   |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine MonthsEndedJuly 2, 2010 |   |
|                   |   | (Successor)                   |    |   | (Predecessor) |   |   | (Successor) |   |   | (Predecessor) |   |   | (Predecessor) |   |
|  Operating income |   |                          |    |   |   |   |   |   |   |   |   |   |   |   |   |
|  VED              |   | $                             | 15,517  |   |   | $ | 16,232 |   |   | $ | 27,266 |   |   | $ | 16,463 |   |   | $ | 43,367 |   |
|  Satcom equipment |   |                          | 6,195   |   |   |   | 1,566 |   |   |   | 8,053 |   |   |   | 1,210 |   |   |   | 5,927 |   |
|  Other            |   |                          | (14,776 | ) |   |   | (8,245 | ) |   |   | (31,779 | ) |   |   | (15,632 | ) |   |   | (19,310 | ) |
|                   |   | $                             | 6,936   |   |   | $ | 9,553 |   |   | $ | 3,540 |   |   | $ | 2,041 |   |   | $ | 29,984 |   |

----

Table of Contents

|                          |   | Fiscal Year                   |   |
|-------------------------------|--------|-------------------------------|--------|
|                          |   | 2011                          |   |   | 2010 |   |   | 2011 |   |   | 2010 |   |
|                          |   | Three MonthsEndedJuly 1, 2011 |   |   | Three MonthsEndedJuly 2, 2010 |   |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine MonthsEndedJuly 2, 2010 |   |
|                          |   | (Successor)                   |   |   | (Predecessor) |   |   | (Successor) |   |   | (Predecessor) |   |   | (Predecessor) |   |
| Net (loss) income             |   | $                             | (1,832 | ) |   | $ | 4,211 |   |   | $ | (9,005 | ) |   | $ | (4,730 | ) |   | $ | 12,544 |   |
| Depreciation and amortization |   |                          | 7,438  |   |   |   | 2,768 |   |   |   | 11,109 |   |   |   | 4,117 |   |   |   | 8,253 |   |
| Interest expense, net         |   |                          | 6,811  |   |   |   | 3,780 |   |   |   | 10,949 |   |   |   | 5,788 |   |   |   | 11,516 |   |
| Income tax expense            |   |                          | 1,957  |   |   |   | 1,562 |   |   |   | 1,462 |   |   |   | 983 |   |   |   | 5,924 |   |
| EBITDA                        |   | $                             | 14,374 |   |   | $ | 12,321 |   |   | $ | 14,515 |   |   | $ | 6,158 |   |   | $ | 38,237 |   |

|       |   | Fiscal Year                          |   |
|------------|--------|--------------------------------------|--------|
|       |   | 2011                                 |   |   | 2010 |   |   | 2011 |   |   | 2010 |   |
|       |   |   Three MonthsEndedJuly 1, 2011 |   |   | Three MonthsEndedJuly 2, 2010 |   |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   |   | Nine Months EndedJuly 2, 2010 |   |
|       |   | (Successor)                          |   |   | (Predecessor) |   |   | (Successor) |   |   | (Predecessor) |   |   | (Predecessor) |   |
| Customer A |   |                                 | 13     | % |   |   | 14 | % |   |   | 14 | % |   |   | 12 | % |   |   | 13 | % |
| Customer B |   |                                 | 19     | % |   |   | * |   |   |   | 14 | % |   |   | * |   |   |   | * |   |

|            |   |
|-----------------|--------|
| * Less than 10% |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |

----

Table of Contents

|                                                                        |   |   |    |   |   |   |    | Guarantor    |   |   | Non-Guarantor |   |   | Consolidating |    |   | Consolidated |   |
|-----------------------------------------------------------------------------|--------|--------|---------|--------|--------|--------|---------|--------------|--------|--------|---------------|--------|--------|---------------|---------|--------|--------------|--------|
|                                                                        |   | Parent |    |   | Issuer |   |    | Subsidiaries |   |   | Subsidiaries  |   |   | Eliminations  |    |   | Total        |   |
| Assets                                                                      |   |   |    |   |   |   |    |         |   |   |          |   |   |          |    |   |         |   |
| Cash and cash equivalents                                                   |   | $      | -       |   |   | $      | -       |         |   | $      | 30,549        |   |   | $             | 1,375   |   |         | $      | - |   |   | $ | 31,924 |   |
| Restricted cash                                                             |   |   | -       |   |   |   | -       |         |   |   | 1,442         |   |   |          | 96      |   |         |   | - |   |   |   | 1,538 |   |
| Accounts receivable, net                                                    |   |   | -       |   |   |   | -       |         |   |   | 27,398        |   |   |          | 17,430  |   |         |   | - |   |   |   | 44,828 |   |
| Inventories                                                                 |   |   | -       |   |   |   | -       |         |   |   | 61,172        |   |   |          | 22,774  |   |         |   | (1,009 | ) |   |   | 82,937 |   |
| Deferred tax assets                                                         |   |   | -       |   |   |   | -       |         |   |   | 9,829         |   |   |          | 604     |   |         |   | - |   |   |   | 10,433 |   |
| Intercompany receivable                                                     |   |   | -       |   |   |   | -       |         |   |   | 13,387        |   |   |          | 26,900  |   |         |   | (40,287 | ) |   |   | - |   |
| Prepaid and other current assets                                            |   |   | 1,183   |   |   |   | 67      |         |   |   | 3,247         |   |   |          | 1,450   |   |         |   | 383 |   |   |   | 6,330 |   |
| Total current assets                                                        |   |   | 1,183   |   |   |   | 67      |         |   |   | 147,024       |   |   |          | 70,629  |   |         |   | (40,913 | ) |   |   | 177,990 |   |
| Property, plant and equipment, net                                          |   |   | -       |   |   |   | -       |         |   |   | 65,475        |   |   |          | 16,178  |   |         |   | - |   |   |   | 81,653 |   |
| Deferred debt issue costs, net                                              |   |   | -       |   |   |   | 14,196  |         |   |   | -             |   |   |          | -       |   |         |   | - |   |   |   | 14,196 |   |
| Intangible assets, net                                                      |   |   | -       |   |   |   | -       |         |   |   | 173,385       |   |   |          | 93,945  |   |         |   | - |   |   |   | 267,330 |   |
| Goodwill                                                                    |   |   | -       |   |   |   | -       |         |   |   | 93,833        |   |   |          | 87,308  |   |         |   | - |   |   |   | 181,141 |   |
| Other long-term assets                                                      |   |   | -       |   |   |   | -       |         |   |   | 5,160         |   |   |          | -       |   |         |   | - |   |   |   | 5,160 |   |
| Investment in subsidiaries                                                  |   |   | 188,446 |   |   |   | 566,535 |         |   |   | 14,748        |   |   |          | -       |   |         |   | (769,729 | ) |   |   | - |   |
| Total assets                                                                |   | $      | 189,629 |   |   | $      | 580,798 |         |   | $      | 499,625       |   |   | $             | 268,060 |   |         | $      | (810,642 | ) |   | $ | 727,470 |   |
|                                                                        |   |   |    |   |   |   |    |         |   |   |          |   |   |          |    |   |         |   |   |   |   |   |   |   |
| Liabilities and stockholders' equity                                        |   |   |    |   |   |   |    |         |   |   |          |   |   |          |    |   |         |   |   |   |   |   |   |   |
| Current portion of long-term debt                                           |   | $      | -       |   |   | $      | 1,500   |         |   | $      | -             |   |   | $             | -       |   |         | $      | - |   |   | $ | 1,500 |   |
| Accounts payable                                                            |   |   | -       |   |   |   | 86      |         |   |   | 13,942        |   |   |          | 11,614  |   |         |   | - |   |   |   | 25,642 |   |
| Accrued expenses                                                            |   |   | 1,089   |   |   |   | 7,235   |         |   |   | 16,301        |   |   |          | 4,628   |   |         |   | (3 | ) |   |   | 29,250 |   |
| Product warranty                                                            |   |   | -       |   |   |   | -       |         |   |   | 3,715         |   |   |          | 1,749   |   |         |   | - |   |   |   | 5,464 |   |
| Income taxes payable                                                        |   |   | -       |   |   |   | -       |         |   |   | 1,404         |   |   |          | 2,271   |   |         |   | - |   |   |   | 3,675 |   |
| Deferred income taxes                                                       |   |   | -       |   |   |   | -       |         |   |   | -             |   |   |          | 14      |   |         |   | - |   |   |   | 14 |   |
| Advance payments from customers                                             |   |   | -       |   |   |   | -       |         |   |   | 8,215         |   |   |          | 7,454   |   |         |   | - |   |   |   | 15,669 |   |
| Billings in excess of costs and estimated earnings on uncompleted contracts |   |   | -       |   |   |   | -       |         |   |   | 2,788         |   |   |          | -       |   |         |   | - |   |   |   | 2,788 |   |
| Intercompany payable                                                        |   |   | -       |   |   |   | 1,401   |         |   |   | -             |   |   |          | -       |   |         |   | (1,401 | ) |   |   | - |   |
| Total current liabilities                                                   |   |   | 1,089   |   |   |   | 10,222  |         |   |   | 46,365        |   |   |          | 27,730  |   |         |   | (1,404 | ) |   |   | 84,002 |   |
| Deferred income taxes                                                       |   |   | -       |   |   |   | -       |         |   |   | 60,967        |   |   |          | 25,904  |   |         |   | - |   |   |   | 86,871 |   |
| Long-term debt, less current portion                                        |   |   | -       |   |   |   | 362,043 |         |   |   | -             |   |   |          | -       |   |         |   | - |   |   |   | 362,043 |   |
| Other long-term liabilities                                                 |   |   | -       |   |   |   | -       |         |   |   | 5,577         |   |   |          | 437     |   |         |   | - |   |   |   | 6,014 |   |
| Total liabilities                                                           |   |   | 1,089   |   |   |   | 372,265 |         |   |   | 112,909       |   |   |          | 54,071  |   |         |   | (1,404 | ) |   |   | 538,930 |   |
| Common stock                                                                |   |   | -       |   |   |   | -       |         |   |   | -             |   |   |          | -       |   |         |   | - |   |   |   | - |   |
| Parent investment                                                           |   |   | -       |   |   |   | 211,100 |         |   |   | 376,152       |   |   |          | 210,200 |   |         |   | (797,452 | ) |   |   | - |   |
| Equity investment in subsidiary                                             |   |   | -       |   |   |   | -       |         |   |   | 9,356         |   |   |          | -       |   |         |   | (9,356 | ) |   |   | - |   |
| Additional paid-in capital                                                  |   |   | 197,320 |   |   |   | -       |         |   |   | -             |   |   |          | -       |   |         |   | - |   |   |   | 197,320 |   |
| Accumulated other comprehensive income                                      |   |   | 225     |   |   |   | 225     |         |   |   | 162           |   |   |          | 63      |   |         |   | (450 | ) |   |   | 225 |   |
| (Accumulated deficit) retained earnings                                     |   |   | (9,005  | )      |   |   | (2,792  | )            |   |   | 1,046         |   |   |          | 3,726   |   |         |   | (1,980 | ) |   |   | (9,005 | ) |
| Total stockholders’ equity                                            |   |   | 188,540 |   |   |   | 208,533 |         |   |   | 386,716       |   |   |          | 213,989 |   |         |   | (809,238 | ) |   |   | 188,540 |   |
| Total liabilities and stockholders' equity                                  |   | $      | 189,629 |   |   | $      | 580,798 |         |   | $      | 499,625       |   |   | $             | 268,060 |   |         | $      | (810,642 | ) |   | $ | 727,470 |   |

----

Table of Contents

|                                                                         |   |   |   |   |   |   |   | Guarantor    |   |   | Non-Guarantor |   |   | Consolidating |   |   | Consolidated |   |
|------------------------------------------------------------------------------|--------|--------|--------|--------|--------|--------|--------|--------------|--------|--------|---------------|--------|--------|---------------|--------|--------|--------------|--------|
|                                                                         |   | Parent |   |   | Issuer |   |   | Subsidiaries |   |   | Subsidiaries  |   |   | Eliminations  |   |   | Total        |   |
|  Sales                                                                  |   | $      | -      |   |   | $      | -      |         |   | $      | 73,133        |   |   | $             | 50,735 |   |         | $      | (19,662 | ) |   | $ | 104,206 |   |
|  Cost of sales                                                          |   |   | -      |   |   |   | -      |         |   |   | 57,229        |   |   |          | 39,914 |   |         |   | (20,066 | ) |   |   | 77,077 |   |
|  Gross profit                                                           |   |   | -      |   |   |   | -      |         |   |   | 15,904        |   |   |          | 10,821 |   |         |   | 404 |   |   |   | 27,129 |   |
|  Operating costs and expenses:                                          |   |   |   |   |   |   |   |         |   |   |          |   |   |          |   |   |         |   |   |   |   |   |   |   |
|  Research and development                                               |   |   | -      |   |   |   | -      |         |   |   | 1,015         |   |   |          | 2,254  |   |         |   | - |   |   |   | 3,269 |   |
|  Selling and marketing                                                  |   |   | -      |   |   |   | -      |         |   |   | 2,900         |   |   |          | 2,400  |   |         |   | - |   |   |   | 5,300 |   |
|  General and administrative                                             |   |   | 600    |   |   |   | (12    | )            |   |   | 4,886         |   |   |          | 953    |   |         |   | - |   |   |   | 6,427 |   |
|  Amortization of acquisition-related intangible assets                  |   |   | -      |   |   |   | -      |         |   |   | 2,618         |   |   |          | 2,235  |   |         |   | - |   |   |   | 4,853 |   |
|  Strategic alternative transaction expenses                             |   |   | 334    |   |   |   | -      |         |   |   | -             |   |   |          | 10     |   |         |   | - |   |   |   | 344 |   |
|  Total operating costs and expenses                                     |   |   | 934    |   |   |   | (12    | )            |   |   | 11,419        |   |   |          | 7,852  |   |         |   | - |   |   |   | 20,193 |   |
|  Operating (loss) income                                                |   |   | (934   | )      |   |   | 12     |         |   |   | 4,485         |   |   |          | 2,969  |   |         |   | 404 |   |   |   | 6,936 |   |
|  Interest expense, net                                                  |   |   | -      |   |   |   | 6,812  |         |   |   | 3             |   |   |          | (4     | )      |         |   | - |   |   |   | 6,811 |   |
| (Loss) income before income tax expense and equity in income of subsidiaries |   |   | (934   | )      |   |   | (6,800 | )            |   |   | 4,482         |   |   |          | 2,973  |   |         |   | 404 |   |   |   | 125 |   |
|  Income tax expense  (benefit)                                |   |   | 1,164  |   |   |   | (2,787 | )            |   |   | 3,463         |   |   |          | (37    | )      |         |   | 154 |   |   |   | 1,957 |   |
|  Equity in income of subsidiaries                                       |   |   | 266    |   |   |   | 4,279  |         |   |   | 300           |   |   |          | -      |   |         |   | (4,845 | ) |   |   | - |   |
|  Net (loss) income                                                      |   | $      | (1,832 | )      |   | $      | 266    |         |   | $      | 1,319         |   |   | $             | 3,010  |   |         | $      | (4,595 | ) |   | $ | (1,832 | ) |

|                                                                               |   |   |    |   |   |   |    | Guarantor    |   |   | Non-Guarantor |   |   | Consolidating |   |   | Consolidated |   |
|------------------------------------------------------------------------------------|--------|--------|---------|--------|--------|--------|---------|--------------|--------|--------|---------------|--------|--------|---------------|--------|--------|--------------|--------|
|                                                                               |   | Parent |    |   | Issuer |   |    | Subsidiaries |   |   | Subsidiaries  |   |   | Eliminations  |   |   | Total        |   |
|  Sales                                                                        |   | $      | -       |   |   | $      | -       |         |   | $      | 118,502       |   |   | $             | 77,177 |   |         | $      | (31,669 | ) |   | $ | 164,010 |   |
|  Cost of sales                                                                |   |   | -       |   |   |   | -       |         |   |   | 91,395        |   |   |          | 60,857 |   |         |   | (31,179 | ) |   |   | 121,073 |   |
|  Gross profit                                                                 |   |   | -       |   |   |   | -       |         |   |   | 27,107        |   |   |          | 16,320 |   |         |   | (490 | ) |   |   | 42,937 |   |
|  Operating costs and expenses:                                                |   |   |    |   |   |   |    |         |   |   |          |   |   |          |   |   |         |   |   |   |   |   |   |   |
|  Research and development                                                     |   |   | -       |   |   |   | -       |         |   |   | 1,630         |   |   |          | 3,802  |   |         |   | - |   |   |   | 5,432 |   |
|  Selling and marketing                                                        |   |   | -       |   |   |   | -       |         |   |   | 4,375         |   |   |          | 3,627  |   |         |   | - |   |   |   | 8,002 |   |
|  General and administrative                                                   |   |   | 903     |   |   |   | (25     | )            |   |   | 6,817         |   |   |          | 1,857  |   |         |   | - |   |   |   | 9,552 |   |
|  Amortization of acquisition-related intangible assets                   |   |   | -       |   |   |   | -       |         |   |   | 3,928         |   |   |          | 3,354  |   |         |   | - |   |   |   | 7,282 |   |
|  Strategic alternative transaction expenses                                   |   |   | 9,119   |   |   |   | -       |         |   |   | -             |   |   |          | 10     |   |         |   | - |   |   |   | 9,129 |   |
|  Total operating costs and expenses                                           |   |   | 10,022  |   |   |   | (25     | )            |   |   | 16,750        |   |   |          | 12,650 |   |         |   | - |   |   |   | 39,397 |   |
|  Operating (loss) income                                                      |   |   | (10,022 | )      |   |   | 25      |         |   |   | 10,357        |   |   |          | 3,670  |   |         |   | (490 | ) |   |   | 3,540 |   |
|  Interest expense (income), net                                               |   |   | -       |   |   |   | 10,626  |         |   |   | 325           |   |   |          | (2     | )      |         |   | - |   |   |   | 10,949 |   |
|  Loss (gain) on debt extinguishment, net                                      |   |   | -       |   |   |   | 253     |         |   |   | (119          | )      |   |          | -      |   |         |   | - |   |   |   | 134 |   |
|  (Loss) income before income tax expense and equity in income of subsidiaries |   |   | (10,022 | )      |   |   | (10,854 | )            |   |   | 10,151        |   |   |          | 3,672  |   |         |   | (490 | ) |   |   | (7,543 | ) |
|  Income tax (benefit) expense                                                 |   |   | (3,809  | )      |   |   | (4,125  | )            |   |   | 9,636         |   |   |          | (54    | )      |         |   | (186 | ) |   |   | 1,462 |   |
|  Equity in (loss) income of subsidiaries                                      |   |   | (2,792  | )      |   |   | 3,937   |         |   |   | 531           |   |   |          | -      |   |         |   | (1,676 | ) |   |   | - |   |
|  Net (loss) income                                                            |   | $      | (9,005  | )      |   | $      | (2,792  | )            |   | $      | 1,046         |   |   | $             | 3,726  |   |         | $      | (1,980 | ) |   | $ | (9,005 | ) |

----

Table of Contents

|                                                                                               |   |   |     |   |   |   |     | Guarantor    |   |   | Non-Guarantor |    |   | Consolidated |   |
|----------------------------------------------------------------------------------------------------|--------|--------|----------|--------|--------|--------|----------|--------------|--------|--------|---------------|---------|--------|--------------|--------|
|                                                                                               |   | Parent |     |   | Issuer |   |     | Subsidiaries |   |   | Subsidiaries  |    |   | Total        |   |
| Cash flows from operating activities                                                               |   |   |     |   |   |   |     |         |   |   |          |    |   |         |   |
| Net cash provided by operating activities                                                          |   | $      | -        |   |   | $      | -        |         |   | $      | 7,340         |    |   | $            | -      |   |   | $ | 7,340 |   |
| Cash flows from investing activities                                                               |   |   |     |   |   |   |     |         |   |   |          |    |   |         |   |   |   |   |   |   |
| Capital expenditures                                                                               |   |   | -        |   |   |   | -        |         |   |   | (1,834        | )       |   |         | (649   | ) |   |   | (2,483 | ) |
| Acquisition of predecessor entity                                                                  |   |   | -        |   |   |   | (370,490 | )            |   |   | -             |    |   |         | -      |   |   |   | (370,490 | ) |
| Net cash used in investing activities                                                              |   |   | -        |   |   |   | (370,490 | )            |   |   | (1,834        | )       |   |         | (649   | ) |   |   | (372,973 | ) |
| Cash flows from financing activities                                                               |   |   |     |   |   |   |     |         |   |   |          |    |   |         |   |   |   |   |   |   |
| Equity investment, net                                                                             |   |   | 197,144  |   |   |   | -        |         |   |   | -             |    |   |         | -      |   |   |   | 197,144 |   |
| Proceeds from issuance of Successor's senior subordinated notes                                    |   |   | -        |   |   |   | 208,550  |         |   |   | -             |    |   |         | -      |   |   |   | 208,550 |   |
| Borrowings under Successor's term loan facility                                                    |   |   | -        |   |   |   | 143,815  |         |   |   | -             |    |   |         | -      |   |   |   | 143,815 |   |
| Debt issue costs                                                                                   |   |   | -        |   |   |   | (3,071   | )            |   |   | -             |    |   |         | -      |   |   |   | (3,071 | ) |
| Redemption and repurchase of Predecessor's senior subordinated notes and floating rate notes  |   |   | -        |   |   |   | (12,000  | )       |   |   | (117,000      | )  |   |         | -      |   |   |   | (129,000 | )  |
| Repayment of borrowings under Predecessor's term loan facility                                     |   |   | -        |   |   |   | -        |         |   |   | (66,000       | )       |   |         | -      |   |   |   | (66,000 | ) |
| Repayment of borrowings under Successor's term loan facility                                       |   |   | -        |   |   |   | (750     | )            |   |   | -             |    |   |         | -      |   |   |   | (750 | ) |
| Intercompany financing activity, net                                                               |   |   | (197,144 | )      |   |   | 33,892   |         |   |   | 163,252       |    |   |         | -      |   |   |   | - |   |
| Net cash provided by (used in) financing activities                                                |   |   | -        |   |   |   | 370,436  |         |   |   | (19,748       | )       |   |         | -      |   |   |   | 350,688 |   |
| Net decrease in cash and cash equivalents                                                          |   |   | -        |   |   |   | (54      | )            |   |   | (14,242       | )       |   |         | (649   | ) |   |   | (14,945 | ) |
| Cash and cash equivalents at beginning of period                                                   |   |   | -        |   |   |   | 54       |         |   |   | 44,790        |    |   |         | 2,025  |   |   |   | 46,869 |   |
| Cash and cash equivalents at end of period                                                         |   | $      | -        |   |   | $      | -        |         |   | $      | 30,548        |    |   | $            | 1,376  |   |   | $ | 31,924 |   |

----

Table of Contents

Item 2.              Management’s Discussion and Analysis of Financial Condition and Results of Operations

----

Table of Contents

|                         |   | Nine Months Ended |   |   |         |   |   |                |   |
|------------------------------|--------|-------------------|--------|--------|--------------|--------|--------|---------------------|--------|
|                         |   | July 1, 2011      |   |   | July 2, 2010 |   |   | Increase (Decrease) |   |
|                         |   |              |   |   | % of         |   |   |                |   |   | % of |   |   |   |   |   |   |   |
|                         |   | Amount            |   |   | Orders       |   |   | Amount              |   |   | Orders |   |   | Amount |   |   | Percent |   |
| Radar and Electronic Warfare |   | $                 | 128.0  |   |         |   | 42     | %                   |   | $ | 102.6 |   |   |   | 36 | % |   | $ | 25.4 |   |   |   | 25 | % |
| Medical                      |   |              | 49.6   |   |         |   | 16     |                |   |   | 52.5 |   |   |   | 19 |   |   |   | (2.9 | ) |   |   | (6 | ) |
| Communications               |   |              | 97.2   |   |         |   | 32     |                |   |   | 98.3 |   |   |   | 35 |   |   |   | (1.1 | ) |   |   | (1 | ) |
| Industrial                   |   |              | 19.5   |   |         |   | 7      |                |   |   | 18.0 |   |   |   | 6 |   |   |   | 1.5 |   |   |   | 8 |   |
| Scientific                   |   |              | 7.7    |   |         |   | 3      |                |   |   | 12.0 |   |   |   | 4 |   |   |   | (4.3 | ) |   |   | (36 | ) |
| Total                        |   | $                 | 302.0  |   |         |   | 100    | %                   |   | $ | 283.4 |   |   |   | 100 | % |   | $ | 18.6 |   |   |   | 7 | % |

----

Table of Contents

| ·   | Radar and Electronic Warfare: The majority of our products in the radar and electronic warfare markets are for domestic and international defense and government end uses. Orders in these markets are primarily comprised of many orders of less than $3.0 million, and the timing of these orders may vary from year to year. On a combined basis, orders for the radar and electronic warfare markets increased approximately 25% from an aggregate of $102.6 million in the first nine months of fiscal year 2010 to an aggregate of $128.0 million in the first nine months of fiscal year 2011. The increase in orders for these combined markets resulted primarily from significant increases in demand for products to support a counter-improvised explosive device (“counter-IED”) program and the Aegis weapons system. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Medical: Orders for our medical products consist of orders for medical imaging applications, such as x-ray imaging, magnetic resonance imaging (“MRI”) and other applications, and for radiation therapy applications for the treatment of cancer. The 6% decrease in medical orders resulted primarily from a sizeable decrease in demand for products to support MRI applications, largely due to the typically irregular timing and size of orders to support those applications. This decrease was partially offset by an increase in demand for products to support x-ray imaging applications due to improving international economic conditions. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Communications: Orders for our communications products consist of orders for commercial communications applications and military communications applications. The 1% decrease in communications orders was primarily due to a decrease in orders for military communications applications, largely as a result of the winding down of Increment One of the Warfighter Information Network – Tactical (“WIN-T”) military communications program. We have substantially completed our involvement in Increment One of this program, although there are opportunities for future participation in subsequent increments of the WIN-T program. This decrease was partially offset by increases in orders to support satellite broadcast applications and international satellite news gathering applications for commercial communications. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Industrial: Orders in the industrial market are cyclical and are generally tied to the state of the economy. The $1.5 million increase in industrial orders was primarily due to the receipt of orders for nuclear magnetic resonance and cargo screening programs, partially offset by a decrease in orders for semiconductor manufacturing applications. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Scientific: Orders in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $4.3 million decrease in scientific orders was primarily the result of the receipt of orders for products to support various domestic and foreign projects in the first nine months of fiscal year 2010 that were not expected to, and did not, repeat in the first nine months of fiscal year 2011. |
|--------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

|                                                  |   | Three Months Ended |   |   |          |   |
|-------------------------------------------------------|--------|--------------------|--------|--------|---------------|--------|
|                                                  |   | July 1, 2011       |   |   | July 2, 2010  |   |   | Increase |   |
|                                                  |   | (Successor)        |   |   | (Predecessor) |   |   | (Decrease) |   |
|                                                  |   |               |   |   | % of          |   |   |   |   |   | % of |   |   |   |   |
|                                                  |   | Amount             |   |   | Sales         |   |   | Amount |   |   | Sales |   |   | Amount |   |
| Sales                                                 |   | $                  | 104.2  |   |          |   | 100.0 | % |   | $ | 93.9 |   |   |   | 100.0 | % |   | $ | 10.3 |   |
| Cost of sales (a)                                     |   |               | 77.1   |   |          |   | 74.0 |   |   |   | 65.0 |   |   |   | 69.2 |   |   |   | 12.1 |   |
| Gross profit                                          |   |               | 27.1   |   |          |   | 26.0 |   |   |   | 28.9 |   |   |   | 30.8 |   |   |   | (1.8 | ) |
| Research and development                              |   |               | 3.3    |   |          |   | 3.2 |   |   |   | 3.5 |   |   |   | 3.7 |   |   |   | (0.2 | ) |
| Selling and marketing                                 |   |               | 5.3    |   |          |   | 5.1 |   |   |   | 5.2 |   |   |   | 5.5 |   |   |   | 0.1 |   |
| General and administrative                            |   |               | 6.4    |   |          |   | 6.1 |   |   |   | 6.4 |   |   |   | 6.8 |   |   |   | - |   |
| Amortization of acquisition-related intangible assets |   |               | 4.9    |   |          |   | 4.7 |   |   |   | 0.7 |   |   |   | 0.7 |   |   |   | 4.2 |   |
| Strategic alternative transaction expenses            |   |               | 0.3    |   |          |   | 0.3 |   |   |   | 3.6 |   |   |   | 3.8 |   |   |   | (3.3 | ) |
| Operating income                                      |   |               | 6.9    |   |          |   | 6.6 |   |   |   | 9.6 |   |   |   | 10.2 |   |   |   | (2.7 | ) |
| Interest expense, net                                 |   |               | 6.8    |   |          |   | 6.5 |   |   |   | 3.8 |   |   |   | 4.0 |   |   |   | 3.0 |   |
| Income before taxes                                   |   |               | 0.1    |   |          |   | 0.1 |   |   |   | 5.8 |   |   |   | 6.2 |   |   |   | (5.7 | ) |
| Income tax expense                                    |   |               | 2.0    |   |          |   | 1.9 |   |   |   | 1.6 |   |   |   | 1.7 |   |   |   | 0.4 |   |
| Net (loss) income                                     |   | $                  | (1.8   | )      |          |   | (1.7 | ) % |   | $ | 4.2 |   |   |   | 4.5 | % |   | $ | (6.0 | ) |
| Other Data:                                           |   |               |   |   |          |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| EBITDA (b)                                            |   | $                  | 14.4   |   |          |   | 13.8 | % |   | $ | 12.3 |   |   |   | 13.1 | % |   | $ | 2.1 |   |

| Note:  Totals may not equal the sum of the components due to independent rounding. Percentages are calculated based on rounded dollar amounts presented. |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (a)     | Cost of sales for the three months ended July 1, 2011 includes $3.9 of utilization of the net increase in cost basis of inventory that resulted from purchase accounting in connection with the Merger. |
|------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)       | EBITDA represents earnings before net interest expense, provision for income taxes and depreciation and amortization. For the reasons listed below, we believe that U.S. generally accepted accounting principles (“GAAP”) based financial information for leveraged businesses such as ours should be supplemented by EBITDA so that investors better understand our financial performance in connection with their analysis of our business: |
|------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | EBITDA is a component of the measures used by our board of directors and management team to evaluate our operating performance; |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------|

|   | • | our senior secured credit facilities contain a covenant that requires us to maintain a total leverage ratio that contains EBITDA as a component, and our management team uses EBITDA to monitor compliance with this covenant; |
|--------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | EBITDA is a component of the measures used by our management team to make day-to-day operating decisions; |
|--------|---------|-----------------------------------------------------------------------------------------------------------|

----

Table of Contents

|   | • | EBITDA facilitates comparisons between our operating results and those of competitors with different capital structures and, therefore, is a component of the measures used by the management to facilitate internal comparisons to competitors’ results and our industry in general; and |
|--------|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | • | the payment of management bonuses is contingent upon, among other things, the satisfaction by us of certain targets that contain EBITDA as a component. |
|--------|---------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | Other companies may define EBITDA differently and, as a result, our measure of EBITDA may not be directly comparable to EBITDA of other companies. Although we use EBITDA as a financial measure to assess the performance of our business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate our business. When analyzing our performance, EBITDA should be considered in addition to, and not as a substitute for or superior to, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | For a reconciliation of Net Income to EBITDA, see Note 13 of the accompanying unaudited condensed consolidated financial statements. |
|--------|--------------------------------------------------------------------------------------------------------------------------------------|

|                         |   | Three Months Ended |   |   |          |   |   |                |   |
|------------------------------|--------|--------------------|--------|--------|---------------|--------|--------|---------------------|--------|
|                         |   | July 1, 2011       |   |   | July 2, 2010  |   |   |                |   |   |   |   |
|                         |   | (Successor)        |   |   | (Predecessor) |   |   | Increase (Decrease) |   |
|                         |   |               |   |   | % of          |   |   |                |   |   | % of |   |   |   |   |   |   |   |
|                         |   | Amount             |   |   | Sales         |   |   | Amount              |   |   | Sales |   |   | Amount |   |   | Percent |   |
| Radar and Electronic Warfare |   | $                  | 47.1   |   |          |   | 45     | %                   |   | $ | 35.4 |   |   |   | 37 | % |   | $ | 11.7 |   |   |   | 33 | % |
| Medical                      |   |               | 16.6   |   |          |   | 16     |                |   |   | 17.7 |   |   |   | 19 |   |   |   | (1.1 | ) |   |   | (6 | ) |
| Communications               |   |               | 32.2   |   |          |   | 31     |                |   |   | 32.6 |   |   |   | 35 |   |   |   | (0.4 | ) |   |   | (1 | ) |
| Industrial                   |   |               | 6.0    |   |          |   | 6      |                |   |   | 5.6 |   |   |   | 6 |   |   |   | 0.4 |   |   |   | 7 |   |
| Scientific                   |   |               | 2.3    |   |          |   | 2      |                |   |   | 2.6 |   |   |   | 3 |   |   |   | (0.3 | ) |   |   | (12 | ) |
| Total                        |   | $                  | 104.2  |   |          |   | 100    | %                   |   | $ | 93.9 |   |   |   | 100 | % |   | $ | 10.3 |   |   |   | 11 | % |

| ·   | Radar and Electronic Warfare: The majority of our products in the radar and electronic warfare markets are for domestic and international defense and government end uses. The timing of orders receipts and subsequent shipments in these markets may vary from year to year. On a combined basis, sales for these two markets increased approximately 33% from an aggregate of $35.4 million in the three months ended July 2, 2010 to an aggregate of $47.1 million in the three months ended July 1, 2011. This increase was due entirely to an increase in demand for products to support a counter-IED program for which production shipments began in the most recent quarter. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| ·   | Medical: Sales of our medical products consist of sales for medical imaging applications, such as x-ray imaging, MRI and other applications, and for radiation therapy applications for the treatment of cancer. The 6% decrease in sales of our medical products was primarily due to a decrease in sales of products to support MRI applications, largely because of the typically irregular timing and size of orders to support those applications. Partially offsetting this decrease, sales of products to support x-ray imaging applications increased during the three months ended July 1, 2011. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Communications: Sales of our communications products consist of sales for commercial communications applications and military communications applications. The 1% decrease in sales in the communications market was primarily due to decreases in sales to support military communications applications, largely as a result of the winding down of the WIN-T military communications program. This decrease was partially offset by an increase in sales of products to support satellite broadcast applications for commercial communications. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Industrial: Sales in the industrial market are cyclical and are generally tied to the state of the economy. The $0.4 million increase in sales of industrial products in the most recent period was primarily due to increased sales to support mass spectrometry and industrial processing applications. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Scientific: Sales in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $0.3 million decrease in scientific sales was primarily the result of the timing of shipments for various scientific programs. |
|--------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                         |   | Three Months Ended |   |
|----------------------------------------------|--------|--------------------|--------|
|                                         |   | July 1,            |   |   | July 2, |   |
|                                         |   | 2011               |   |   | 2010 |   |
|                                         |   | (Successor)        |   |   | (Predecessor) |   |
| Company sponsored                            |   | $                  | 3.3    |   |   | $ | 3.5 |   |
| Customer sponsored, charged to cost of sales |   |               | 3.2    |   |   |   | 4.0 |   |
|                                         |   | $                  | 6.5    |   |   | $ | 7.5 |   |

----

Table of Contents

----

Table of Contents

|                                                  |   | Fiscal Year               |   |   |                             |   |
|-------------------------------------------------------|--------|---------------------------|--------|--------|----------------------------------|--------|
|                                                  |   | 2011                      |   |   | 2010                             |   |   |   |   |
|                                                  |   | February 11, 2011         |   |   | October 2, 2010                  |   |   | Nine Months Ended |   |   |   |   |
|                                                  |   | toJuly 1, 2011(Successor) |   |   | toFebruary 10, 2011(Predecessor) |   |   | July 1, 2011(Combined) |   |   | July 2, 2010(Predecessor) |   |   | Increase (Decrease) |   |
|                                                  |   |                      |   |   | % of                             |   |   |   |   |   | % of |   |   |   |   |   | % of |   |   |   |   |   | % of |   |   |   |   |
|                                                  |   | Amount                    |   |   | Sales                            |   |   | Amount |   |   | Sales |   |   | Amount |   |   | Sales |   |   | Amount |   |   | Sales |   |   | Amount |   |
| Sales                                                 |   | $                         | 164.0  |   |                             |   | 100.0 | % |   | $ | 124.2 |   |   |   | 100.0 | % |   | $ | 288.2 |   |   |   | 100.0 | % |   | $ | 265.0 |   |   |   | 100.0 | % |   | $ | 23.2 |   |
| Cost of sales (a)                                     |   |                      | 121.1  |   |                             |   | 73.8 |   |   |   | 91.4 |   |   |   | 73.6 |   |   |   | 212.5 |   |   |   | 73.7 |   |   |   | 185.9 |   |   |   | 70.2 |   |   |   | 26.6 |   |
| Gross profit                                          |   |                      | 42.9   |   |                             |   | 26.2 |   |   |   | 32.8 |   |   |   | 26.4 |   |   |   | 75.8 |   |   |   | 26.3 |   |   |   | 79.1 |   |   |   | 29.8 |   |   |   | (3.3 | ) |
| Research and development                              |   |                      | 5.4    |   |                             |   | 3.3 |   |   |   | 5.0 |   |   |   | 4.0 |   |   |   | 10.4 |   |   |   | 3.6 |   |   |   | 9.3 |   |   |   | 3.5 |   |   |   | 1.1 |   |
| Selling and marketing                                 |   |                      | 8.0    |   |                             |   | 4.9 |   |   |   | 8.3 |   |   |   | 6.7 |   |   |   | 16.3 |   |   |   | 5.7 |   |   |   | 15.4 |   |   |   | 5.8 |   |   |   | 0.9 |   |
| General and administrative                            |   |                      | 9.6    |   |                             |   | 5.9 |   |   |   | 11.9 |   |   |   | 9.6 |   |   |   | 21.4 |   |   |   | 7.4 |   |   |   | 18.6 |   |   |   | 7.0 |   |   |   | 2.8 |   |
| Amortization of acquisition-related intangible assets |   |                      | 7.3    |   |                             |   | 4.5 |   |   |   | 1.0 |   |   |   | 0.8 |   |   |   | 8.3 |   |   |   | 2.9 |   |   |   | 2.1 |   |   |   | 0.8 |   |   |   | 6.2 |   |
| Strategic alternative transaction expenses            |   |                      | 9.1    |   |                             |   | 5.5 |   |   |   | 4.7 |   |   |   | 3.8 |   |   |   | 13.8 |   |   |   | 4.8 |   |   |   | 3.8 |   |   |   | 1.4 |   |   |   | 10.0 |   |
| Operating income                                      |   |                      | 3.5    |   |                             |   | 2.1 |   |   |   | 2.0 |   |   |   | 1.6 |   |   |   | 5.6 |   |   |   | 1.9 |   |   |   | 30.0 |   |   |   | 11.3 |   |   |   | (24.4 | ) |
| Interest expense, net                                 |   |                      | 10.9   |   |                             |   | 6.6 |   |   |   | 5.8 |   |   |   | 4.7 |   |   |   | 16.7 |   |   |   | 5.8 |   |   |   | 11.5 |   |   |   | 4.3 |   |   |   | 5.2 |   |
| Loss on debt extinguishment, net                      |   |                      | 0.1    |   |                             |   | 0.1 |   |   |   | - |   |   |   | 0.0 |   |   |   | 0.1 |   |   |   | 0.0 |   |   |   | - |   |   |   | - |   |   |   | 0.1 |   |
| (Loss) income before taxes                            |   |                      | (7.5   | )      |                             |   | (4.6 | ) |   |   | (3.7 | ) |   |   | (3.0 | ) |   |   | (11.3 | ) |   |   | (3.9 | ) |   |   | 18.5 |   |   |   | 7.0 |   |   |   | (29.8 | ) |
| Income tax expense                                    |   |                      | 1.5    |   |                             |   | 0.9 |   |   |   | 1.0 |   |   |   | 0.8 |   |   |   | 2.4 |   |   |   | 0.8 |   |   |   | 5.9 |   |   |   | 2.2 |   |   |   | (3.5 | ) |
| Net (loss) income                                     |   | $                         | (9.0   | )      |                             |   | (5.5 | ) % |   | $ | (4.7 | ) |   |   | (3.8 | ) % |   | $ | (13.7 | ) |   |   | (4.8 | ) % |   | $ | 12.5 |   |   |   | 4.7 | % |   | $ | (26.2 | ) |
| Other Data:                                           |   |                      |   |   |                             |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| EBITDA (b)                                            |   | $                         | 14.5   |   |                             |   | 8.8 | % |   | $ | 6.2 |   |   |   | 5.0 | % |   | $ | 20.7 |   |   |   | 7.2 | % |   | $ | 38.2 |   |   |   | 14.4 | % |   | $ | (17.5 | ) |

| Note:  Totals may not equal the sum of the components due to independent rounding. Percentages are calculated based on rounded dollar amounts presented. |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (a)    | Cost of sales for the period February 11, 2011 to July 1, 2011 includes $7.5 of utilization of the net increase in cost basis of inventory that resulted from purchase accounting in connection with the Merger. |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (b)    | EBITDA represents earnings before net interest expense, provision for income taxes and depreciation and amortization. For the reasons listed below, we believe that U.S. generally accepted accounting principles (“GAAP”) based financial information for leveraged businesses such as ours should be supplemented by EBITDA so that investors better understand our financial performance in connection with their analysis of our business: |
|------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|         • | EBITDA is a component of the measures used by our board of directors and management team to evaluate our operating performance; |
|----------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------|

|         • | our senior secured credit facilities contain a covenant that requires us to maintain a total leverage ratio that contains EBITDA as a component, and our management team uses EBITDA to monitor compliance with this covenant; |
|---------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|         • | EBITDA is a component of the measures used by our management team to make day-to-day operating decisions; |
|----------------------------------------------------|-----------------------------------------------------------------------------------------------------------|

|         • | EBITDA facilitates comparisons between our operating results and those of competitors with different capital structures and, therefore, is a component of the measures used by the management to facilitate internal comparisons to competitors’ results and our industry in general; and |
|----------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|        • | the payment of management bonuses is contingent upon, among other things, the satisfaction by us of certain targets that contain EBITDA as a component. |
|----------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------|

| Other companies may define EBITDA differently and, as a result, our measure of EBITDA may not be directly comparable to EBITDA of other companies. Although we use EBITDA as a financial measure to assess the performance of our business, the use of EBITDA is limited because it does not include certain material costs, such as interest and taxes, necessary to operate our business. When analyzing our performance, EBITDA should be considered in addition to, and not as a substitute for or superior to, net income, cash flows from operating activities or other statements of operations or statements of cash flows data prepared in accordance with GAAP. |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                         |   | Nine Months Ended |   |   |         |   |   |                |   |
|------------------------------|--------|-------------------|--------|--------|--------------|--------|--------|---------------------|--------|
|                         |   | July 1, 2011      |   |   | July 2, 2010 |   |   | Increase (Decrease) |   |
|                         |   |              |   |   | % of         |   |   |                |   |   | % of |   |   |   |   |   |   |   |
|                         |   | Amount            |   |   | Sales        |   |   | Amount              |   |   | Sales |   |   | Amount |   |   | Percent |   |
| Radar and Electronic Warfare |   | $                 | 114.5  |   |         |   | 40     | %                   |   | $ | 96.9 |   |   |   | 36 | % |   | $ | 17.6 |   |   |   | 18 | % |
| Medical                      |   |              | 49.9   |   |         |   | 17     |                |   |   | 54.6 |   |   |   | 21 |   |   |   | (4.7 | ) |   |   | (9 | ) |
| Communications               |   |              | 97.7   |   |         |   | 34     |                |   |   | 90.4 |   |   |   | 34 |   |   |   | 7.3 |   |   |   | 8 |   |
| Industrial                   |   |              | 17.4   |   |         |   | 6      |                |   |   | 16.0 |   |   |   | 6 |   |   |   | 1.4 |   |   |   | 9 |   |
| Scientific                   |   |              | 8.7    |   |         |   | 3      |                |   |   | 7.1 |   |   |   | 3 |   |   |   | 1.6 |   |   |   | 23 |   |
| Total                        |   | $                 | 288.2  |   |         |   | 100    | %                   |   | $ | 265.0 |   |   |   | 100 | % |   | $ | 23.2 |   |   |   | 9 | % |

| ·   | Radar and Electronic Warfare: The majority of our sales in the radar and electronic warfare markets are for products for domestic and international defense and government end uses. The timing of the receipt of orders and subsequent shipments in these markets may vary from year to year. On a combined basis, sales for these markets increased approximately 18% from an aggregate of $96.9 million in the nine months ended July 2, 2010 to an aggregate of $114.5 million in the nine months ended July 1, 2011. The increase was primarily due to an approximately $12 million increase in sales of products to support a counter-IED program for which production shipments began in fiscal year 2011. Sales of products to support the Aegis weapons system and airborne electronic countermeasure programs increased, as well. |
|--------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Medical: Sales of our medical products consist of sales for medical imaging applications, such as x-ray imaging, MRI and other applications, and for radiation therapy applications for the treatment of cancer. The 9% decrease in sales of our medical products was primarily due to a decrease in sales of products to support MRI applications, largely because of the typically irregular timing and size of orders to support those applications. This decrease was partially offset by an increase in sales of products for x-ray imaging applications. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| ·   | Communications: Sales of our communications products consist of sales for commercial communications applications and military communications applications. The 8% increase in sales in the communications market was primarily attributable to increases in sales to support military communications applications, primarily tactical common data link (“TCDL”) products for intelligence, surveillance and reconnaissance (“ISR”) applications. In commercial communications, sales of products to support satellite news gathering and satellite and terrestrial broadcast applications also increased. |
|--------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Industrial: Sales in the industrial market are cyclical and are generally tied to the state of the economy. The $1.4 million increase in sales of industrial products was primarily due to increased sales to support mass spectrometry, semi-conductor manufacturing and other industrial applications. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ·   | Scientific: Sales in the scientific market are historically one-time projects and can fluctuate significantly from period to period. The $1.6 million increase in scientific sales was the result of increased sales for various domestic and foreign scientific programs. |
|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                         |   | Nine Months Ended |   |
|----------------------------------------------|--------|-------------------|--------|
|                                         |   | July 1,           |   |   | July 2, |   |
|                                         |   | 2011              |   |   | 2010 |   |
| Company sponsored                            |   | $                 | 10.4   |   |   | $ | 9.3 |   |
| Customer sponsored, charged to cost of sales |   |              | 12.3   |   |   |   | 11.7 |   |
|                                         |   | $                 | 22.7   |   |   | $ | 21.0 |   |

----

Table of Contents

----

Table of Contents

----

Table of Contents

|                      |   | July 1,     |   |   | October 1,    |   |
|---------------------------|--------|-------------|--------|--------|---------------|--------|
|                      |   | 2011        |   |   | 2010          |   |
|                      |   | (Successor) |   |   | (Predecessor) |   |
| Cash and cash equivalents |   | $           | 31.9   |   |          | $      | 42.8 |   |
| Working capital           |   | $           | 94.0   |   |          | $      | 44.8 |   |

|                                                 |   | Fiscal Year                     |   |
|------------------------------------------------------|--------|---------------------------------|--------|
|                                                 |   | 2011                            |   |   | 2010 |   |
|                                                 |   | February 11, 2011toJuly 1, 2011 |   |   | October 2, 2010toFebruary 10, 2011 |   | Nine MonthsEndedJuly 2, 2010 |   |
|                                                 |   | (Successor)                     |   |   | (Predecessor) |   |   | (Predecessor) |   |
| Net cash provided by operating activities            |   | $                               | 7.3    |   |   | $ | 4.3 |   |   | $ | 22.5 |   |
| Net cash used in investing activities                |   | $                               | (372.9 | ) |   | $ | (2.5 | ) |   | $ | (2.9 | ) |
| Net cash provided by financing activities            |   | $                               | 350.7  |   |   | $ | 2.2 |   |   | $ | 1.4 |   |
| Net (decrease) increase in cash and cash equivalents |   | $                               | (14.9  | ) |   | $ | 4.0 |   |   | $ | 21.0 |   |

----

Table of Contents

----

Table of Contents

|                                     |   |   |    |   | Fiscal Year                  |   |
|------------------------------------------|--------|--------|---------|--------|------------------------------|--------|
|                                     |   | Total  |    |   | 2011(remaining three months) |   |   |   | 2012 - 2013 |   |   |   | 2014 - 2015 |   |   | Thereafter |   |
| Operating leases                         |   | $      | 5,736   |   |                         | $      | 344 |   |   | $ | 2,133 |   |   | $ | 884 |   |   | $ | 2,375 |   |
| Purchase commitments                     |   |   | 31,565  |   |                         |   | 18,598 |   |   |   | 12,967 |   |   |   | - |   |   |   | - |   |
| Debt obligations                         |   |   | 364,250 |   |                         |   | 375 |   |   |   | 3,000 |   |   |   | 3,000 |   |   |   | 357,875 |   |
| Interest on debt obligations             |   |   | 164,599 |   |                         |   | 6,235 |   |   |   | 50,094 |   |   |   | 49,790 |   |   |   | 58,480 |   |
| Uncertain tax positions                  |   |   | 7,814   |   |                         |   | 2,983 |   |   |   | 4,831 |   |   |   | - |   |   |   | - |   |
|    Total cash obligations |   | $      | 573,964 |   |                         | $      | 28,535 |   |   | $ | 73,025 |   |   | $ | 53,674 |   |   | $ | 418,730 |   |
| Standby letters of credit                |   | $      | 3,935   |   |                         | $      | 3,935 |   |   |   |   |   |   |   |   |   |   |   |   |   |

----

Table of Contents

Item 3.              Quantitative and Qualitative Disclosures About Market Risk

----

Table of Contents

Item 4.              Controls and Procedures

----

Table of Contents

Part II:  OTHER INFORMATION

Item 1.              Legal Proceedings

Item 1A.   Risk Factors

Item 2.              Unregistered Sales of Equity Securities and Use of Proceeds

Item 3.              Defaults Upon Senior Securities

Item 4.              (Removed and Reserved)

Item 5.              Other Information

----

Table of Contents

Item 6.              Exhibits

| No.    |                        |  Description |
|--------|-----------------------------|-------------------|
|   | 31.1                        |              | Certification of Chief Executive Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e), promulgated under the Securities Exchange Act of 1934, as amended. |
|   | 31.2                        |              | Certification of Chief Financial Officer pursuant to Rule 13a-15(e) and Rule 15d-15(e), promulgated under the Securities Exchange Act of 1934, as amended. |
|   | 32.1                        |              | Certifications of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|   | 32.2                        |              | Certifications of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
|   | 101     |              | The following financial statements from the CPI International Holding Corp. Report on Form 10-Q for the quarter ended July 1, 2011, filed with the Securities and Exchange Commission on August 19, 2011, formatted in XBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of July 1, 2011 and October 1, 2010, (ii) Condensed Consolidated Statements of Operations and Comprehensive Income for the Three Months Ended July 1, 2011 and July 2, 2010, (iii) Condensed Consolidated Statements of Operations and Comprehensive Income for the Periods February 11, 2011 to July 1, 2011, October 2, 2010 to February 10, 2011 and Nine Months Ended July 2, 2010, (iv) Condensed Consolidated Statements of Cash Flows for the Periods February 11, 2011 to July 1, 2011, October 2, 2010 to February 10, 2011 and Nine Months Ended July 2, 2010, and (v) Notes to Unaudited Condensed Consolidated Financial Statements, tagged as blocks of text. |

----

Table of Contents

|                         | CPI INTERNATIONAL HOLDING CORP.                                                                                      |
|------------------------------|----------------------------------------------------------------------------------------------------------------------|
|                         |                                                                                                                 |
|                         |                                                                                                                 |
|                         |                                                                                                                 |
| Dated: August 19, 2011 | /s/ JOEL A. LITTMAN                                                                                                  |
|                         | Joel A. LittmanChief Financial Officer, Treasurer and Secretary(Duly Authorized Officer and Chief Financial Officer) |

----